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Summary 
 
In all higher organisms, the experience of pain is associated with an unpleasant feeling. 
Nevertheless, our ability to perceive pain warns us of harmful threats that originate either 
from the inside of our body or from the environment. Perceiving pain relies on a well-
functioning nociceptive system, which starts with nociceptive fibers conveying noxious inputs 
from the periphery to the first relay platform in the central nervous system (CNS), namely the 
spinal dorsal horn. At this site, inputs are modulated and filtered by a network of excitatory 
and inhibitory interneurons. The final output is relayed via projection neurons to higher 
cortical areas in the brain where pain becomes a conscious experience. However, in some 
cases nociception becomes dysfunctional and eventually leads to persistent and chronic pain. 
Underlying symptoms of chronic pain are allodynia, where innocuous stimuli such as light-
touch become painful and hyperalgesia defined as an enhanced sensitivity to noxious stimuli. 
Studies have shown that reduced GABAergic or glycinergic neurotransmission in the dorsal 
horn leads to increased nociceptive signaling to the brain. This indicates that a functional 
inhibitory network in the dorsal horn is important for avoiding uncontrolled transmission of 
nociceptive stimuli to higher levels of the central nervous system. Several studies in rodent 
models of neuropathic or inflammatory pain have demonstrated that GABAA receptors 
containing the α2 subunit (α2-GABAA receptors) in addition to certain glycine receptors play a 
key role in the inhibitory control of nociceptive signaling at the spinal cord level.  
In the three experimental studies of this thesis, I used optogenetics and whole-cell patch-
clamp recordings to provide a detailed analysis of inhibitory neurotransmission in the spinal 
dorsal horn of mice. In the first chapter, I focused on a genetic mouse model of diminished 
GABAergic inhibition at the spinal cord level. The mice used in this study were hoxb8α2-/- 
mice which lack α2-GABAA receptors in the spinal cord up to the cervical segment C4. 
Although these mice lacked a GABAA receptor subtype (α2-GABAA receptors) that is critically 
involved in spinal nociceptive control and although GABAergic inhibitory postsynaptic 
currents (GABA-IPSCs) recorded from excitatory superficial dorsal horn neurons were 
reduced, these mice did not show exaggerated pain responses indicating that some 
compensatory mechanisms were active in these mice. Several potential compensatory 
mechanisms were investigated. No significant differences were found for the decay kinetics 
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of GABA-IPSCs. No changes were found in the amplitude of glycinergic IPSCs or of membrane 
currents evoked by extracellular application of GABA. I also did not find significant changes in 
the amplitudes of sensory afferent evoked excitatory postsynaptic currents (EPSCs), which 
are known to be under control by presynaptic GABAA receptors. By contrast, I found 
increased bicuculline-sensitive (GABAergic) tonic membrane currents in hoxb8α2-/- mice. 
Furthermore, in immunohistochemical experiments, I found a significant increase in 
serotonin immunoreactivity and in the expression of the serotonin producing enzyme 
tryptophan hydroxylase (TPH2). Both the increases in tonic GABAergic currents and in 
serotonergic input to the spinal cord may on a behavioral level compensate for the loss of 
synaptic GABAergic inhibition and may explain why hoxb8α2-/- mice lack a pronociceptive 
phenotype.   
In the second chapter, Part A, I aimed at identifying the origin of inhibitory inputs onto 
excitatory lamina II (LII) neurons. To this end, I used laser scanning photostimulation (LSPS) in 
combination with whole-cell patch-clamp recordings in spinal cord slices of BAC transgenic 
vGAT::ChR2 mice. These mice express the blue light-activated ion channel channelrhodopsin 
2 in all inhibitory neurons of the CNS including the spinal cord. About half (46%) of the sites 
triggering inhibitory input to the recorded neurons were located in the superficial dorsal 
horn, one third was located in the deep dorsal horn, and 21% were in the white matter. 
These results indicate that inhibitory input to LII neurons does not only originate from 
inhibitory neurons of the same lamina but also from deep dorsal horn interneurons and very 
likely from inhibitory fiber tracts descending from higher CNS areas. This interpretation is 
consistent with results described in Part B, where I characterized inhibitory 
neurotransmission in GlyT2::Cre;vGAT::ChR2 mice in which dorsal horn glycinergic neurons 
were locally ablated by virus-mediated cre-dependent diphtheria toxin expression. In these 
experiments, I found a reduction of inhibitory neurotransmission to excitatory LII neurons by 
55%. Because most of the glycinergic neurons are located in the deep dorsal horn, these 
results also support a strong contribution of deep dorsal horn neurons to inhibition of 
neurons and circuits of LII.   
Taken together, this thesis provides new insights on the organization of inhibitory 
neurotransmission in the spinal dorsal horn and on potential mechanisms contributing to a 
compensation of compromised synaptic inhibition in spinal dorsal horn nociceptive circuits. 
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Resumé 
 
La douleur est une sensation désagréable perçue lorsqu’un danger réel ou potentiel menace 
l’intégrité de l’organisme. La perception de la douleur témoigne du bon fonctionnement de 
notre système nociceptif. Ce dernier est composé de fibres périphériques qui transmettent 
les influx nociceptifs de la périphérie au premier relais du système nerveux central, la corne 
dorsale. Celle-ci module et filtre les informations par un réseau d'interneurones excitateurs 
et inhibiteurs. L'information est ensuite relayée par un neurone de projection au cerveau où 
le signal nociceptif active des mécanismes complexes aboutissant à la perception de la 
douleur par l’individu. Dans certains cas, le dysfonctionnement du système nociceptif conduit 
à une douleur persistante qui, à long terme, peut devenir chronique. Les symptômes sous-
jacents de la douleur chronique sont l'allodynie, par laquelle des stimuli indolores tels qu'une 
légère pression, deviennent douloureux, et l’hyperalgésie qui est définie comme une 
sensibilité accrue aux stimuli douloureux. Des recherches ont démontré qu'une diminution 
de neurotransmission GABAergique ou glycinergique dans la corne dorsale provoquait une 
augmentation des informations douloureuses transmises au cerveau. Ceci indique qu'un 
réseau inhibiteur fonctionnel dans la corne dorsale permet d'éviter la transmission 
incontrôlée de stimuli douloureux aux niveaux supérieurs du système nerveux central. 
Jusqu'ici, les études ont démontré que des benzodiazépines spécifiques à un sous-type de 
récepteur GABAA, à savoir les récepteurs α2-GABAA, soulagent la douleur chez les rongeurs 
souffrant de douleur neuropathique ou inflammatoire. Ceci indique que si l'on rétablit la 
neurotransmission inhibitrice de la moelle épinière en facilitant la neurotransmission 
GABAergique, par exemple, l’on approcherait de manière rationnelle le traitement des 
symptômes de la douleur chronique.  
 
Dans les trois études expérimentales de cette thèse, j'ai combiné l’optogénétique et les 
enregistrements électrophysiologiques, afin de fournir une analyse détaillée de la 
neurotransmission inhibitrice au niveau de la corne dorsale de la moelle épinière chez la 
souris. Dans le premier chapitre, j’ai focalisé mon travail sur un modèle de souris qui 
présente une diminution de l’inhibition GABAergique au niveau de la moelle épinière. Les 
souris utilisées dans cette étude étaient hoxb8α2-/-, qui sont dépourvues de récepteurs α2-
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GABAA dans la moelle épinière jusqu'au segment cervical C4. Bien que ces souris ne 
possèdent pas un sous-type de récepteur GABAA (α2-GABAA), crucialement impliqué dans le 
control nociceptif au niveau de la moelle épinière, et qu’elles aient une diminution des 
courants postsynaptiques GABAergiques inhibiteurs (CPSI-GABA) enregistrés depuis des 
neurones excitateurs de la corne dorsale superficielle, ces souris n’ont pas manifesté de 
réponses exagérées à la douleur, indiquant ainsi la possible présence de mécanismes 
compensatoires actifs. Plusieurs de ces mécanismes compensatoires ont été étudiés. Aucune 
différence significative n’a été trouvée au niveau de la décroissance cinétique des CPSI-GABA. 
Par ailleurs, je n’ai pas trouvé de changements significatifs au niveau de l’amplitude des 
courants postsynaptiques excitateurs évoqués par les fibres sensorielles afférentes, connues 
pour être sous contrôle de récepteurs GABAA présynaptiques. En revanche, j’ai trouvé que les 
courants membranaires toniques (GABAergiques) chez les souris hoxb8α2-/- avaient un 
accroissement de sensibilité à la bicuculline. De plus, dans les expériences 
d’immunohistochimie, j’ai trouvé un accroissement significatif de l’immunoréactivité à la 
sérotonine ainsi qu’à l’enzyme produisant la sérotonine, la tryptophane hydroxylase (TPH2). 
L’accroissement de courants toniques GABAergiques ainsi que la contribution 
sérotoninergique au niveau de la moelle épinière peuvent, à l’échelle comportementale, 
compenser la perte d’inhibition GABAergique synaptique et ainsi expliquer pourquoi les 
souris hoxb8α2-/- ne présentent pas de phénotype pronociceptif.  
 
Dans le second chapitre, Partie A, j'ai tenté d’identifier les sources d’influx inhibiteurs 
s’exerçant sur les neurones excitateurs de la lamina II (LII). Pour ce faire, j'ai employé la 
technique de laser scanning photostimulation (LSPS) sur des tranches de moelle épinière de 
souris vGAT::ChR2 BAC transgéniques. Ces souris expriment dans tous les neurones 
inhibiteurs du système nerveux central (SNC), le canal ionique channelrhodopsin 2, un canal 
qui s’active à la lumière bleue. Environ la moitié (46 %) des sites provoquant des influx 
inhibiteurs aux neurones enregistrés proviennent de la corne dorsale superficielle, un tiers 
est localisé dans la corne dorsale profonde et 21 % proviennent de la substance blanche. Ces 
résultats indiquent que les influx inhibiteurs s’exerçant sur les neurones de la LII ne 
proviennent pas entièrement de neurones inhibiteurs de la même lamina, mais aussi 
d’interneurones de la corne dorsale profonde ainsi que très certainement de faisceaux de 
fibres inhibitrices descendant du SNC. Cette interprétation est très cohérente avec les 
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résultats décrits dans la partie B, où j’ai caractérisé la neurotransmission inhibitrice chez les 
souris GlyT2::Cre;vGAT::ChR2 chez lesquelles les neurones glycinergiques de la corne dorsale 
ont été localement éliminées par l’expression de la toxine de la diphtérie transmise par le 
virus AAV-flex-DTA. Dans ces expériences, j’ai trouvé une réduction d’environ 55% de la 
neurotransmission inhibitrice chez les neurones excitateurs de la LII. Parce que la plupart des 
neurones glycinergiques sont localisés dans la corne dorsale profonde, ces résultats 
soutiennent l’idée d’une forte contribution des neurones de la corne dorsale profonde à 
l’inhibition des neurones et circuits de la LII.  
 
Cette thèse, dans son ensemble, apporte un nouvel aperçu sur l’organisation de la 
neurotransmission inhibitrice dans la corne dorsale de la moelle épinière ainsi que sur des 
potentiels mécanismes contribuant à compenser l’inhibition synaptique qui serait 
compromise dans la corne dorsale de la moelle épinière au niveau des circuits nociceptifs.
 
  
8 
Abbreviations 
 
2-AG: 2-arachidonyl-glycerol 
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General introduction 
 
I. Pain 
Pain is a conscious perception generated in the brain as a consequence of nociception. 
Nociception refers to the processing and encoding of the noxious stimuli taking place in the 
peripheral and central nervous system (Loeser and Treede, 2008). Our ability to sense 
impending damage to the organism has a direct impact on our life span and well-being since 
it makes us take the appropriate measures to avoid further damage. Recurrent trauma and 
infections are responsible for reduced life expectancy among humans suffering from 
congenital insensitivity to pain (Cox et al., 2006). As pain is a subjective experience, it has 
been defined according to the International Association for the Study of Pain (IASP) as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage”. Physiological pain, also known as acute pain, 
is potentially triggered by noxious stimuli, such as cold or heat, irritant chemicals and 
mechanical pressure (Blondell et al., 2013). Pain, however, can also persist beyond the acute 
threats, and sustain pain far beyond the initial cause (Luo et al., 2014). 
 
II. Physiology of acute pain 
Anatomy of the nociceptive pathway 
i. Dorsal horn inputs: Primary sensory fibers  
Primary sensory fibers have a peripheral axon terminal that responds to sensory stimuli. 
Noxious or innocuous stimuli depolarize primary sensory fibers at their peripheral terminals 
and elicit a generator potential through the activation of voltage-gated sodium channels (e.g. 
Nav 1.8) (Waxman and Zamponi, 2014). The signals propagate along the peripheral nerve 
until they reach the spinal dorsal horn. At this site, the nociceptors make synapses with local 
excitatory and inhibitory interneurons or projection neurons, which ultimately convey 
nociceptive information to higher levels of the CNS (Figure 1). Sensory fibers respond either 
to noxious (heat, pressure, cold) or innocuous inputs (i.e., pleasant touch). Accordingly, 
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primary sensory fibers can be classified as either low-threshold mechanoreceptors (LTMRs, 
Aβ-fibers) that respond to light touch and tactile inputs, or high-threshold, slowly conducting 
afferents, which require noxious stimuli to be activated. Aβ-fibers are thickly myelinated, 
which endows them with high conduction velocities (Leem et al., 1993; Abraira and Ginty, 
2013). Nociceptive Aδ-fibers are only thinly myelinated and C-fibers are devoid of 
myelination. Conduction velocities of nerve fibers depend on the degree of myelination. 
Typically, C-fibers have conduction velocities of 0.5-2 m/s; Aδ 12-30 m/s and Aβ 30-70 m/s 
(Kakigi et al., 2003; Djouhri and Lawson, 2004). Aδ-fibers usually mediate sharp and localized 
pain sensations, whereas C-fibers elicit slower and more diffuse sensations. C-fibers can be 
sub-classified into two groups depending on their responsiveness to neurotrophic factors: 
peptidergic or non-peptidergic (Snider and McMahon, 1998b). Most peptidergic C-fibers 
express the capsaicin receptor TRPV1, involved in mediating heat pain (Caterina and Julius, 
2001; McCoy et al., 2013) and in addition to glutamate, release calcitonin gene-related 
peptide (CGRP) or substance P (SP). Non-peptidergic C-fibers are characterized by the binding 
of isolectin B4 (IB4+) and are implicated in mechanical (Bogen et al., 2008) and possibly 
thermal nociception (Malin et al., 2006). Recently, a population of low-threshold C-fibers, 
characterized by the expression of tyrosine hydroxylase and of the vesicular glutamate 
transporter subtype 3 (VgluT3), was shown to play a major role in mechanical allodynia 
following inflammation, nerve injury or trauma (Seal et al., 2009). The broad distribution of 
primary sensory fibers terminating within different dorsal horn laminae suggests functional 
distinctions in their contribution to the activity of dorsal horn neurons.  
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Figure 1. Nociceptive pathway. Noxious stimuli are sensed by specific receptors or ion channels located on the 
terminals of nociceptors which are sensitive to heat, mechanical stimuli, protons and cold. Thinly myelinated Aδ 
fibers or unmyelinated C-fibers convey these signals to the spinal dorsal horn, where they are modulated, 
processed, and ultimately transmitted to the brain, where the sensation of pain is experienced and becomes 
conscious. Modified from Scholz and Woolf (2002). 
ii. Laminar organization 
Rexed (1952) divided the grey matter of the cat spinal dorsal horn into a series of parallel 
layers. This scheme has in the meantime been applied to other species. The spinal cord can 
be broadly subdivided into a dorsal horn (DH), the sensory part, and a ventral horn (VH), 
involved in motor control. The dorsal horn harbors a plethora of neuronal subpopulations 
that are targeted by primary afferent terminals (Figure 2) and terminals from supraspinal 
sites. In total, the spinal cord is subdivided in ten different laminae. 
Lamina I (LI) is the most superficial layer of the dorsal horn, and not thicker than two cell 
body diameters. It contains projection neurons (discussed in Ascending pathways) that 
receive direct monosynaptic and polysynaptic inputs from peptidergic C-fiber and Aδ-fibers 
but also a wide range of excitatory and inhibitory interneurons. Central terminals of Aδ and 
peptidergic C-fibers can be found in this layer.  
Lamina II (LII), also known as Substantia gelatinosa (SG) due to its translucid appearance, is 
located below LI. This translucency reflects the lack of axon myelination from C-fibers, which 
terminate in the area. Very often, LI and LII are named the superficial dorsal horn (sdh). LII is 
densely innervated by peptidergic and nonpeptidergic C-fibers. Peptidergic C-fibers 
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terminate in LIIouter (LIIo), while non-peptidergic terminate at the inner LII (LIIi), close to the 
border with LIII (Snider and McMahon, 1998a; Braz et al., 2014). In addition, LII harbors a 
network of inhibitory (GABAergic and glycinergic) and excitatory (glutamatergic) interneurons 
that modulate the incoming nociceptive inputs. The most ventral part of LII i is characterized 
by excitatory glutamatergic neurons expressing protein kinase C isoform γ (PKCγ), which are 
innervated by non-nociceptive primary afferents (Neumann et al., 2008). The inhibitory 
population accounts for approximately one-third of the total amount of interneurons. The 
majority of inhibitory neurons of LI/LII are purely GABAergic (Popratiloff et al., 1996; Todd et 
al., 1996b). 
The deeper dorsal horn laminae (LIII-LVI) are mainly innervated by Aβ and Aδ-fibers (Naim et 
al., 1997). They nevertheless also receive inputs from nociceptive C-fibers (Basbaum et al., 
2009; Foster et al., 2015). Like LI, LIII and LV also contain projection neurons. LIII projection 
neurons receive inputs from peptidergic C-fibers, and LV. Projection neurons are innervated 
by non-nociceptive Aβ and Aδ fibers, and indirect (polysynaptic) C-fiber inputs. Neurons in LV 
are termed wide dynamic-range neurons (WDRs) because they respond to noxious and 
innocuous stimuli (i.e., noxious and innocuous). Inhibitory neurons in this region co-release 
both GABA and glycine. 
Rexed’s anatomical organization of the laminae is well defined and highlights the different 
projection patterns and circuits of primary afferents and dorsal horn neurons. However, the 
functional neuronal circuits within the laminae (interlaminae) and between laminae 
(translaminar) are still poorly understood.  
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Figure 2. Laminar organization of the spinal cord and primary afferent inputs. A, Rat spinal cord hemisection 
immunostained for NeuN that specifically labels neurons. Dotted lines indicate boundaries of the different 
laminae. B, Scheme representing the preferred termination sites of primary afferent fibers onto the different 
laminae (Todd, 2010). 
iii.  Biochemical markers of dorsal horn interneurons 
Identifying markers for interneurons is important to gain a better understanding of their 
physiological and morphological properties. Many neurochemical markers have been 
identified so far to label excitatory and inhibitory interneurons. For example, different 
subpopulations of excitatory interneurons were shown to express the calcium-binding 
proteins calbindin-D 28k (Antal et al., 1991) and calretinin, PKCγ  (Polgar et al., 1999), c-Maf, 
a transcription factor (Hu et al., 2012), neurokinin B (Polgar et al., 2006), and neurotensin 
(Todd et al., 1992). Gastrin-releasing peptide (GRP) labels a subpopulation of excitatory 
neurons involved in itch (Mishra and Hoon, 2013). We recently investigated cholecystokinin 
(CCK)-expressing cells, which appear to be an additional subpopulation of excitatory neurons 
(Dr. S. Haueter, V. Jamarillo, unpublished data). Markers of inhibitory neurons have also been 
extensively studied (Ross et al., 2010; Polgar et al., 2013; Wildner et al., 2013). So far, galanin, 
neuronal nitric oxide synthase (nNOS), parvalbumin (PV), and neuropeptide Y (NPY) were 
identified as different markers of inhibitory interneurons responding differently to painful 
stimulation and targeting different cell types (Polgar et al., 2013).  
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The generation of eGFP reporter mouse lines facilitated the morphological and 
electrophysiological analysis of the different types of neuron in the dorsal horn (Tamamaki et 
al., 2003; Zeilhofer et al., 2005). Although there is no reliable immunocytochemical marker 
for glutamatergic cell bodies, it is generally accepted that neurons not immunoreactive for 
GABA or glycine are glutamatergic, and release L-glutamate (Todd et al. 2010). Glutamatergic 
axons can be identified in VgluT2::eGFP mice in which the vesicular glutamate transporter 
(VgluT) is tagged by an eGFP reporter (Todd et al., 2003). VgluT1 has been shown to be 
expressed by Aβ-fibers, and VgluT2 by C-fibers and Aδ-fibers (Scherrer et al., 2010). Finally, 
VglutT3 was found to be exclusively expressed by C-LTMRs (Seal et al., 2009; Seal, 2016). 
Although the expression of VgluTs in spinal dorsal horn neurons during development is not 
well characterized, it was nevertheless demonstrated that deep dorsal horn neurons 
transiently expressed VgluT3 to convey normal mechanical pain sensation (Peirs et al., 2015).  
Visualizing GABAergic or glycinergic neurons is possible with GAD67eGFP, GAD65::eGFP or 
GlyT2::eGFP mouse lines, where GAD, the GABA synthesizing-enzymes (Tamamaki et al., 
2003; Heinke et al., 2004) or GlyT2, the neuronal glycine transporter are marked with eGFP 
(Zeilhofer et al., 2005).  
iv.  Morphological and biophysical hallmarks of dorsal horn interneurons 
Studies have used dendritic tree reconstruction and electrophysiological recordings to 
distinguish four morphological classes of cells (Grudt and Perl, 2002; Prescott and De 
Koninck, 2002; Hantman et al., 2004; Heinke et al., 2004; Yasaka et al., 2010; Punnakkal et al., 
2014). These cell types are known as islet, central, radial and vertical neurons. Islet cells are 
mostly found in LIIi. Their dendritic tree predominantly extends into a rostrocaudal direction. 
Activation of islet cells triggers the release of GABA, defining them as inhibitory neurons (Lu 
and Perl, 2003; Maxwell et al., 2007). Islet cells receive monosynaptic inputs from C-fibers, 
and display tonic firing patterns, a good indicator of inhibitory GABAergic or glycinergic 
phenotype (Zeilhofer et al., 2012). Central cells are found in both LIIi and LIIo. Although their 
dendritic tree extends with the same orientation as islet cells, they remain shorter. A 
particularity of central cells is that they can be either excitatory or inhibitory, and can fire 
either transiently or tonically. Like islet cells, central cells are monosynaptically targeted by C-
fibers, and Aδ-fibers (Grudt and Perl, 2002). Radial cells expand their dendrites in 
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rostrocaudal and dorsoventral orientations. Most radial cells are excitatory (Yasaka et al., 
2010) although some inhibitory cells were reported (Maxwell et al., 2007). Finally, vertical 
cells are nested in LIIo, and their dendritic tree extends dorsoventrally. Although vertical cells 
are associated with excitatory neurons, some exceptions have been reported (Heinke et al., 
2004; Maxwell et al., 2007) (Figure 3). Despite this extensive morphological characterization 
of dorsal horn interneurons, a substantial 30 % of cells remain unclassified. 
 
Figure 3. Morphology and action potential firing pattern of dorsal horn interneurons. A, The dendritic tree of 
Islet and central cells mainly spreads in a rostrocaudal orientation. Dendrites from radial cells extend in all 
directions, and vertical cells have a dominant ventral arborization of their dendrites. B, Tonic cells fire action 
potentials (AP) at high frequency with constant intervals throughout the duration of the stimulus. 
Phasic/transient cells show an immediate onset of APs separated by silent periods. Delayed cells fire the first 
action potential with a certain delay (Zeilhofer et al., 2012). 
 
v. Ascending pathways and brain centers for pain perception 
Projection neurons provide the major output from the dorsal horn to higher levels of the 
CNS. However, in LI they account for only 5 to 10 % of all LI neurons (Spike et al., 2003). 
Although most projection neurons are clustered in LI, scattered expression is also observed 
throughout LIII-LV. LI projection neurons receive direct inputs from LII inhibitory and 
excitatory interneurons as well as from C-fibers (Gobel et al., 1980). The neurokinin 1 
receptor (NK1R) is expressed by projection neurons and becomes active upon binding of 
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substance P (Todd et al., 2002). In addition, LI projection neurons were shown to receive 
indirect inputs from Aβ-fibers via a polysynaptic connection with LII vertical cells (Kato et al., 
2009; Kosugi et al., 2013). Before reaching supraspinal territories, projection neurons target 
their axon to the contralateral side and project rostrally towards higher areas in the 
brainstem through the white matter until terminating in various brainstem and thalamic 
nuclei. These pathways constitute the spinoreticulothalamic and spinothalamic tracts, 
respectively. Anterograde and retrograde tracing have revealed the different termination 
sites of LI projection neurons (Gauriau and Bernard, 2004). These results led to the 
conclusion that the main targets of LI projection neurons were the caudal ventrolateral 
medulla (CVLM), the nucleus of the solitary tract (NTS), the lateral parabrachial area (LPb), 
the periaqueductal grey matter (PAG) and the thalamus (Gauriau and Bernard, 2004). From 
the brainstem and thalamus nuclei, relay neurons then project their axons onto different 
cortical areas of the brain, leaving the “unconscious” nociceptive pathway for conscious 
perception of pain in the cortex. Several cortical areas are involved in representing pain 
(Apkarian, 2013; Lee and Tracey, 2013) such as the somatosensory cortex, the cingulate 
cortex, and the insular cortex (Basbaum et al., 2009). 
vi.  Descending pathways 
Dorsal horn neurons also receive either negative or positive control from supraspinal 
descending fibers that influence the transmission of pain messages (Gebhart, 2004). 
Important descending pathways include the serotonergic system, originating from the 
nucleus raphe magnus (of the rostral ventromedial medulla, RVM) (Belin et al., 1983; Antal et 
al., 1996), the noradrenergic pathway from the locus coeruleus (Moore and Bloom, 1979), 
and GABAergic/glycinergic inputs, originating from the RVM (Kato et al., 2006). The RVM 
sends projections to LI, LII and LV dorsal horn neurons (Hylden et al., 1985). As mentioned 
earlier, neurons in these laminae are also engaged by nociceptors, which suggest a critical 
contribution of these descending pathways to the modulation of nociceptive signaling. It has 
been shown that activating certain neurons in the RVM could promote either pronociception 
or antinociception in nociceptive signaling of the dorsal horn (Basbaum and Fields, 1984; 
Heinricher and McGaraughty, 1998; Neubert et al., 2004; Lau and Vaughan, 2014). For 
example, the pro- or antinociceptive effects elicited by serotonin (5-HT) rely on the type of 5-
HT receptors expressed by the postsynaptic neurons in the spinal cord. Although it is clear 
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that postsynaptic 5-HT1a receptors inhibit spinal dorsal horn neurons, divergent results were 
reported with 5-HT3 (Ali et al., 1996; Rahman et al., 2004; Suzuki et al., 2004; Fukushima et 
al., 2009; Bardin, 2011; Gu et al., 2011). However, it was shown in a study that 5-HT3 was 
expressed on presynaptic terminals of GABAergic neurons, facilitating GABAergic inhibitory 
synaptic transmission in the sdh (Fukushima et al., 2009).  
Fast inhibitory neurotransmission 
Inhibitory neurons play a critical role in modulating nociceptive pathways (Lu and Perl, 2010). 
In the spinal dorsal horn, inhibition is mediated by GABA and glycine, two fast inhibitory 
neurotransmitters (Zeilhofer et al., 2012). Ionotropic GABAA and glycine receptors belong to 
the Cys-loop superfamily of ligand-gated ion channels, which includes also nicotinic 
acetylcholine receptors and ionotropic serotonin (5-HT3) receptors (Olsen and Sieghart, 2008, 
2009). GABAAR and GlyR are permeable to chloride ions and, to a lesser extent, to 
bicarbonate (Blaesse et al., 2009; Passlick et al., 2013) and thus upon activation of their pore 
hyperpolarize the cell. 
i. GABAA receptors 
Mammalian GABAA receptors are heteropentameric ligand-gated ion channels composed 
from a repertoire of 19 different subunits: α1-α6, β1-β3, γ1-γ3, δ, ε, π, τ, and ρ1-ρ3. The 
subunit composition of most GABAA receptor subtypes is well established and there is 
general agreement that the most likely subunit stoichiometry in the CNS is 2α/2β/1γ (Boileau 
et al., 2005) (Figure 4). However, GABAA receptors may display different stoichiometries or 
express only α and β subunits (Jones and Henderson, 2007). 
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Figure 4. GABAA receptor subunits and structure. A, Dendogram of mammalian GABAA receptor showing the 
subunit repertoire. B, In the CNS, heteropentameric GABAA receptors are mainly composed by 2α/2β/1γ 
subunits. The GABA neurotransmitters bind on two α/β interfaces, and allow the channel to open, allowing Cl- 
ions to flow through the pore. Benzodiazepines (BDZ) bind on the α/γ interface and increase the Cl- 
conductance. Modified from Zeilhofer et al. (2012). 
In the spinal cord, the most abundant configuration is α2-α3/β3/γ2, as opposed to the brain 
where it is mainly α1/β2/γ2 (Wisden et al., 1991; Laurie et al., 1992; Bohlhalter et al., 1996). 
GABAA receptor subunit arrangement can influence the affinity of the receptor to GABA, the 
channel conductance, pharmacological properties, and the location of GABAA receptor on the 
cell membrane. For instance, α1, α2, α3 subunits as well as β2 and β3 subunits can interact 
directly with gephyrin, a cytoplasmic scaffolding protein believed to anchor postsynaptic 
GABAA receptors as well as glycine receptors to the postsynaptic membrane (Tretter et al., 
2008; Mukherjee et al., 2011; Kowalczyk et al., 2013). In addition, the γ2 subunit was shown 
to be required for synaptic clustering of most GABAA receptor subtypes (Essrich et al., 1998). 
Synaptic GABAA receptors mediate phasic inhibition in the CNS. Conversely, extrasynaptic 
GABAA receptors are generally associated with a δ subunit which substitutes the γ subunit 
and either α4 or α5 subunits. This composition renders extrasynaptic GABAA receptors more 
sensitive to GABA, and makes them mediators of tonic inhibition (Belelli et al., 2009). The 
GABAA receptors α subunits display a differential distribution across the spinal cord. The α1 
subunit is mainly expressed in LIII, the deep dorsal horn and the central canal. The α2 subunit 
is strongly expressed in the sdh and ventral horn, as well as around the central canal. α3 has 
a similar expression pattern as α2, although its expression in the ventral horn is lower. The α4 
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subunit displays a very sparse expression in the spinal cord and finally the α5 subunit is 
mostly expressed in the sdh (Paul et al., 2012) (Figure 5). 
 
Figure 5. Differential distribution of the GABAAR α subunits in the spinal cord. Color-coded images revealing 
the wide-spread distribution of α (1-5) subunits on a coronal hemisection of the spinal cord. The tissue was 
processed for immunoperoxidase stainings with α subunit-specific antibodies. The α1, α2, α3 and α5 subunits 
are strongly expressed in the superficial and deep dorsal horn as well as around the central canal. α2, α3 and α5 
are also expressed in the ventral horn. However, expression of the α4 subunit in the spinal cord remains quite 
sparse. Scale bar: 100 μm. (Paul et al., 2012). 
After release from the presynaptic terminals, GABA binds to an interface formed by α and β 
subunits, which occurs twice in GABAA receptors. GABAA receptors can be modulated by 
endogenous neuromodulators (neurosteroids) or exogenous compounds, including 
benzodiazepines (BDZ), barbiturates, alcohol, and anesthetics (Johnston, 1996; Rudolph and 
Mohler, 2006). BDZ typically bind between γ2 and one α subunit (Mohler et al., 2001). BZD 
site-agonists can also bind to GABAA receptors containing either γ1 or γ3 subunits but with 
reduced affinity (Benke et al., 1996). Only GABAA receptors containing at least one α1, α2, α3 
or α5 subunit are potentiated by BDZs. α4 and α6 do not respond to BZDs (Mohler et al., 
2001). GABAA receptors can be antagonized by bicuculline through competitive inhibition 
with GABA, which ultimately blocks Cl- conductance (Akaike et al., 1985). 
ii. Glycine receptors 
Glycine is another inhibitory neurotransmitter, mostly used in the spinal cord, brainstem, and 
retina (Araki et al., 1988). Glycine receptors are more limited in terms of subunit 
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heterogeneity than GABAA receptors. Their repertoire is restricted to four α subunits and one 
β subunit (Figure 6). Although all five genes encode functional glycine receptors in rodents, in 
humans the glycine receptor α4 subunit (GlyRα4) is not functional due to several mutations 
including a premature stop codon (Laube et al., 2002). Glycine receptors composed solely of 
α subunits remain functional homopentameric glycine-sensitive ion channels, which is not 
the case with homopentameric β glycine receptors. Recent evidence has suggested that, in 
general, functional glycine receptors are heteropentameric and composed of two α subunits 
and three β subunits (Grudzinska et al., 2005) (Figure 6). The interaction between the β 
subunit and the postsynaptic anchoring protein gephyrin targets glycine receptors to the 
synaptic sites (Fritschy et al., 2008). In the immature CNS, it is believed that glycine receptors 
are first expressed as α2 homomeric receptors, which in the mature CNS become either α1β 
or α3β heteromeric receptors, with α1β being the most prevalent configuration (Malosio et 
al., 1991; Takahashi et al., 1992). In the spinal cord, glycine receptors α3 subunit (GlyRα3) are 
restricted to the sdh, which suggests these receptors play a crucial role in spinal inhibitory 
nociceptive processing (Harvey et al., 2004). 
Glycine receptors are selectively antagonized by strychnine, an alkaloid from the Indian plant 
Strychnos nux vomica. This drug distinguishes glycine receptors from GABAA receptors, but 
also from the excitatory N-methyl D-aspartate receptors (NMDARs), on which glycine also has 
a binding site (Johnson and Ascher, 1987; Berger et al., 1998). 
 
Figure 6. Glycine receptor subunits and structure. A, Repertoire of the glycine receptor subunits. B, 
Heteropentameric glycine receptors composed of 2α and 3β subunits. Upon activation, glycine receptors open 
and allow Cl- to flow through the pore. Modified from Zeilhofer et al. (2012) 
 
      
23 
III. Chronic pain  
Chronic pain is a social and economic burden, affecting about 19 % of the adult European 
population of which 40 % claim not being satisfied with their pain therapy (Breivik et al., 
2006). Two main types of chronic pain may be distinguished, namely inflammatory pain, 
which follows tissue injury, and neuropathic pain, induced by nerve injury (Jensen et al., 
2011). Underlying symptoms of these two conditions include hyperalgesia, defined as 
enhanced pain sensitivity, and allodynia, pain sensitivity to innocuous stimuli (Basbaum et al., 
2009). A major class of analgesic drugs used today are the nonsteroidal anti-inflammatory 
drugs (NSAIDs). Although they relieve patients from inflammatory pain, on the long term, 
these drugs are often associated with gastrointestinal harm (Moore et al., 2014). Similarly, 
opioids, although effective against neuropathic pain in the short term, over time may cause 
addiction. Therefore, despite major advances in pharmacological research, no drug has to 
this day led to a successful treatment against chronic pain without mediating secondary 
effects such as sedation, addiction or tolerance, to cite just a few. 
Mechanism of diminished spinal inhibition 
i.  Peripheral sensitization 
During inflammation or after tissue damage, primary afferent fibers develop lower excitation 
thresholds in reaction to mechanical and thermal stimuli, and fire action potentials at higher 
frequencies (Schaible and Richter, 2004). This peripheral sensitization is mainly due to the 
exposure of nociceptor terminals to inflammatory mediators released at the site of injury by 
the so-called “inflammatory soup”. These compounds include extracellular protons (involved 
in acidosis), arachidonic acid and other lipid metabolites, serotonin, bradykinin, nucleotides 
and nerve growth factor (NGF), all of which modulate the properties of receptors and ion 
channels located on the nociceptor terminals (Julius and Basbaum, 2001). The abnormal 
activation of nociceptors facilitates the release of the inflammatory mediators from other 
resident cells, namely the keratinocytes and mast cells, which in addition release 
prostaglandins (PGE), protons (H+), and ATP. This process is known as neurogenic 
inflammation (Gold and Gebhart, 2010). An important player in the maintenance of the 
nociceptors’ sensitivity are the NGF activated TrkA receptors (receptor tyrosine kinase A). 
NGF triggers several signaling cascades aimed at increasing the expression levels of receptors 
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(TRPV1r) and ion channels (Na+ channels) on nociceptors, leading to hypersensitivity (Woolf, 
1996) (Sandkuhler, 2009). A consequence of peripheral sensitization is the development of 
primary hyperalgesia, a localized sensitization in the area of the tissue damage. Therefore, 
increased sensitization of nociceptors in the periphery may increase the excitability of spinal 
dorsal horn neurons (Woolf, 1983). 
ii. Central sensitization 
Central sensitization refers to pain originating from enhanced excitability of CNS neurons. It is 
typically associated with allodynia, spontaneous pain and primary and secondary 
hyperalgesia (Latremoliere and Woolf, 2009; Sandkuhler, 2009; Kuner, 2010). Primary and 
secondary hyperalgesia respectively describe increases in pain sensitivity either at the site of 
an injury or in the area surrounding this site.  
ii.1 Alteration in glutamatergic neurotransmission 
Long-term potentiation (LTP) has been shown to be important in the hippocampus for 
reinforcing memory. This activity-dependent sensitization relies on the stimulation of 
presynaptic fibers at high frequency (Bliss and Lomo, 1973). LTP also takes place in the spinal 
cord and involves high or low frequency activity of C-fibers and spinal projection neurons (Liu 
and Sandkuhler, 1997; Ikeda et al., 2006). This mechanism of synaptic potentiation depends 
on NMDARs and T-type voltage-gated calcium channels (Ikeda et al., 2003). In addition, it 
includes also the insertion of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptors (AMPARs) at glutamatergic synapses (Randic et al., 1993). In vivo injection of 
capsaicin (agonist of TRPV1 receptors) or formalin as well as nerve injury can contribute to 
strengthening synaptic transmission between C-fibers and dorsal horn neurons and lead to 
secondary hyperalgesia and allodynia (Ikeda et al., 2003). 
ii.2 Disinhibition of dorsal horn neurons 
Inhibitory neurons are densely distributed in the sdh and, as postulated in the gate control 
theory, a loss of function of these inhibitory interneurons (disinhibition) would lead to 
increased pain (Melzack and Wall, 1965). Further evidence for the importance of these 
inhibitory neurons in regulating pain signals was shown after spinal administration of 
bicuculline and strychnine, whereby rodents developed spontaneous pain (Yaksh, 1989; 
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Sivilotti and Woolf, 1994). A recent publication from our group also demonstrated the 
importance of dorsal horn glycinergic neurotransmission in pain signaling (Foster et al., 
2015). The following paragraphs will introduce different mechanisms involved in 
compromising spinal GABAergic and glycinergic inhibition in neuropathic and inflammatory 
pain. 
It has been demonstrated that injury to peripheral nerves induces a depolarizing shift in the 
chloride equilibrium potential of dorsal horn neurons (Coull et al., 2003). Microglia activated 
by the release of cytokine CCL2 from damaged nerves (Thacker et al., 2009) release brain-
derived neurotrophic factor (BDNF). BDNF binds to trkB receptors on dorsal horn neurons, 
ultimately leading to the down-regulation of KCC2, required for maintaining low levels of 
intracellular chloride (Coull et al., 2005). Consequently, increased intracellular chloride 
concentrations reverse the hyperpolarizing effect of GABA and glycine on dorsal horn 
neurons due to a depolarizing shift in the chloride reversal potential (Coull et al., 2003; Coull 
et al., 2005). 
Partial nerve injury was shown to decrease spinal dorsal horn levels of the GABA synthesizing 
enzyme, glutamic acid decarboxylase (GAD65) (Moore et al., 2002). This leads to reduced 
GABAergic synaptic transmission, possibly explained by apoptosis of GABAergic inhibitory 
neurons (Moore et al., 2002).  
Peripheral inflammation is also a trigger to diminished synaptic inhibition (Harvey et al., 
2004; Reinold et al., 2005). During peripheral inflammation, the expression of specific 
enzymes such as COX2 or mPGES-1 is up-regulated leading to the production of 
pronociceptive and proinflammatory prostaglandin E2 (PGE2) in the spinal cord. Upon binding 
to its receptor (EP2), PGE2 activates protein kinase A (PKA) which induces phosphorylation of 
the α3 subunit-containing glycine receptors (Ahmadi et al., 2002). This reduction in spinal 
glycinergic inhibition leads to mechanical and thermal hyperalgesia in mice. 
Diminished synaptic inhibition may also indirectly originate from a mechanism involving 
endocannabinoids (eCB). Work from our group has demonstrated that upon strong 
stimulation of nociceptive C-fibers, excitatory interneurons from the sdh received less 
GABAergic/glycinergic neurotransmission due to disinhibition of inhibitory presynaptic 
neurons connected to these excitatory neurons (Pernia-Andrade et al., 2009). 
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The common denominator of all these above-mentioned mechanisms is a diminished 
inhibition originating from GABAergic or glycinergic neurons in the dorsal horn leading to 
persistent pain. Therefore, a rational approach for restoring inhibition, and thereby 
reestablish normal pain signaling in the dorsal horn could be to pharmacologically target 
either GABAergic or glycinergic neurons (Figure 7).  
 
Figure 7. Four signaling pathways 
causing disinhibition in pathological pain 
states. (1) PGE2 produced in the spinal 
cord in response to peripheral nerve 
inflammation increases cAMP, which 
ultimately phosphorylates and inhibits 
GlyRs of dorsal horn neurons. (2) BDNF 
released by microglia down-regulates the 
potassium-chloride transporter (KCC2), 
important for maintaining low chloride 
gradients in dorsal horn neurons. As a 
consequence, GABAergic and glycinergic 
neurons become depolarized upon 
activation of their receptors and their 
inputs become less inhibitory (more 
excitatory). (3) Neuromodulators such as eCB inhibit voltage operated calcium channels (VOCC) via Gβγ protein-
coupled CB1 receptors. This leads to a decrease in calcium influx and ultimately to a reduction in 
neurotransmitter release. (4) Down-regulation of the GABA synthesizing enzyme GAD65, which possibly reduces 
the GABA content in inhibitory dorsal horn neurons (Zeilhofer et al., 2015). 
 
Strategies for restoring spinal inhibitory neurotransmission 
i.  GABAA receptor subunit-specific benzodiazepines 
GABAA receptors have been the center of attention for pharmacological drug targeting 
mainly because many spinal dorsal horn inhibitory neurons release both GABA and glycine 
from their terminals, but also because most neurons receive inputs form GABAergic and 
glycinergic neurons (Todd and Sullivan, 1990; Yoshimura and Nishi, 1995; Todd et al., 1996a). 
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Following this logic, GABAergic facilitation should also permit to compensate for a reduction 
in glycinergic inhibition (Ahmadi et al., 2002). Classical BDZs enhance inhibitory 
neurotransmission by binding to four subunits (α1, α2, α3, α5) of GABAA receptors. When 
applied to the spinal cord intraspinally, these classical BDZs can alleviate pathological pain 
(Enna and McCarson, 2006; Knabl et al., 2009). Since GABAA receptors display an array of 
different subunit configurations, which provide them with channel properties and cellular 
localizations, it was important to develop GABAA receptor subtype-selective drugs to 
separate the antihyperalgesic effects from the unwanted ones (i.e., sedation, tolerance, 
addiction). To attribute the different actions of diazepam to single GABAA receptor subtypes, 
point-mutated knock-in mice were generated in which one or several α subunits of GABAA 
receptors were rendered insensitive to diazepam (DZP) (Rudolph and Mohler, 2006; Knabl et 
al., 2008; Knabl et al., 2009; Ralvenius et al., 2015). Through this approach, it was 
demonstrated by some studies that GABAA receptor α subunits contributed to different 
effects of BDZ (Figure 8). 
 
Figure 8. Contribution of the four α-GABAA receptor subtypes to antihyperalgesia and comparison with 
other behavioral effects of BDZs. Spinal antihyperalgesia is mainly mediated by α2-GABAARs and to a lesser 
extent by α3 and α5-GABAARs. The α2-GABAARs also mediate anxiolysis and muscle relaxation. The α1-GABAARs 
mediate sedation and addiction. Modified from Zeilhofer et al.(2015). 
It was evidenced using an inflammatory and neuropathic pain model that α1-GABAAR 
subtypes were involved in mediating sedation, whereas α2 and α3-containing GABAARs 
mediated anxiolysis and pronounced analgesia (Low et al., 2000; Knabl et al., 2008). Further 
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work investigated the roles of α2, α3, and α5-GABAAR subunits to DZP-induced 
antinociception (in an α1 point-mutated background) and found that α2 and α3 GABAAR 
subunits were most relevant to DZP-mediated antihyperalgesia after systemic and intrathecal 
injection of DZP in a model of inflammatory and neuropathic pain (Knabl et al., 2008; 
Ralvenius et al., 2015). These results provided evidence that the spinal cord was a major site 
for benzodiazepine-induced antihyperalgesia. A study from our lab made use of a mouse line 
in which the α2-GABAAR subtype was specifically ablated from the spinal cord and primary 
sensory neurons up to the segment C4 (Witschi et al., 2010; Paul et al., 2014). Using this 
mouse, it was demonstrated that the antihyperalgesic effects of systemically administered 
BDZ originated exclusively from the spinal cord and mediated spinal antihyperalgesia (Rivas 
et al., 2009; Di Lio et al., 2011).  
In addition, it is now clear that developing BDZs devoid of activity at α1-GABAARs is crucial for 
avoiding unwanted effects. Such drugs (e.g. L838417) have already been used in 
inflammatory and neuropathic pain models and have elicited antinociceptive effects without 
sedation (Munro et al., 2009). Altogether, we may conclude that developing compounds with 
increased specificity to α2-GABAARs as well as insensitivity to α1-GABAARs, might offer new 
therapeutic opportunities to restore disinhibition and ultimately mediate spinal 
antihyperalgesia. 
 
IV. Approaches to studying the connectivity and functionality of spinal neurons 
Progress towards a better understanding of the organization and function of neural circuits 
involved in pain signaling relies on the development of useful and novel tools that I shall 
describe in the following section.  
Optogenetics 
i. Channelrhodopsins (ChRs) 
In the last decade, exploiting light has become one of the most widely used strategies to 
study neural connectivity, functionality and dysfunction not only in the brain but also in the 
spinal cord (Zhao et al., 2011; Kato et al., 2013; Foster et al., 2015).  
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ChRs are light-gated cation-selective channels located in the cell membrane, and used as 
photoreceptors in algae during photosynthesis (Nagel et al., 2002). Upon photon absorption, 
ChRs mediate a fast depolarizing inward current due to the channels’ permeability to sodium 
(Na+) and calcium (Ca2+) ions as well as protons (H+) (Nagel et al., 2003). The engineering of 
ChRs has permitted the development of hybrids with improved spectral and kinetics 
properties as well as improved expression on cellular membranes (Lin, 2011). ChRs are 
therefore used to depolarize neuronal membranes with light and therefore control their 
excitability (Boyden et al., 2005; Li et al., 2005; Nagel et al., 2005; Zhang et al., 2006). 
 
Channelrhodopsin (ChR2). Light absorption (λ=473 nm) by the chromophore (all-trans-retinal) causes a 
conformational change from all-trans to 13-cis-retinal. These changes introduce an additional conformational 
change in the channel that leads to the opening of the pore and allows the flow of sodium (Na+), calcium (Ca2+), 
protons (H+) and potassium (K+) ion, involved in depolarizing the cell. Modified from Wong et al.(2012). 
The most commonly used ChR is ChR2, which upon activation can drive spiking with 
millisecond precision. The advantage of selectively activating individual cell populations is 
that it improves our understanding of the role of a specific cell type in a given circuit. For 
example, a study expressed ChR2 in spinal astrocytes to determine the effects of in-situ 
astrocyte activation on pain sensitization (Nam et al., 2016). In this study as in many others 
(Depuy et al., 2011; Yang et al., 2015), viral vectors were used to target ChR2 to a defined cell 
population. In addition to inevitable tissue damage, this approach could lead to gradients of 
transgene expression levels in the infected tissue and variable spreads of the virus in the 
tissue. To circumvent these potential limitations, new technologies allowed the development 
of cell-type specific ChR2-YFP BAC transgenic mouse lines (Zhao et al., 2011). BAC transgenic 
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mice expressing ChR2 are used to specifically activate a wide range of cell types such as 
cholinergic cells (Chat-ChR2) to study the function of these cells in motor circuits (Caggiano 
et al., 2016), or inhibitory cells (vGAT::ChR2-YFP) to investigate the importance of inhibitory 
neurotransmission in spinal pain signaling (Foster et al., 2015). 
Inhibition of neural activity allows assessing the functional role of individual circuit 
components. A widely used inhibitory opsin is the NpHR (halorhodopsin) (Han et al., 2015). 
As opposed to ChR2, NpHR pumps chloride ions into the cell upon light activation and leads 
to hyperpolarization of the cell membrane.  An alternative to NpHRs are the proton pumps 
(ArCh), which also lead to cell hyperpolarization upon light stimulation (Hedrick et al., 2016). 
ii. Laser scanning photostimulation (LSPS) 
Lu and Perl were pioneers in dissecting interneuronal connectivity in the spinal dorsal horn. 
To achieve this they performed paired recordings, which can be very tedious and time 
consuming (Lu and Perl, 2003, 2005) given that one must record from connected pairs of 
neurons. Data obtained from paired recordings is useful for examining interneuronal 
connectivity (Lu and Perl, 2003; Schneider, 2008; Zhang and Schneider, 2011). This technique 
makes it nevertheless difficult to get an overview of patterns of connectivity across neuronal 
populations throughout the dorsal horn. The LSPS technique, instead, circumvents this 
limitation and provides population-wide spatial information on the connectivity between cell 
types. Moreover, it allows rapid sampling across multiple sites in a stimulus pattern. LSPS can 
either be combined with glutamate uncaging (Kato et al., 2007; Kato et al., 2013; Kosugi et 
al., 2013) or with light-sensitive ligand-gated channels (ChR2) (Petreanu et al., 2007). 
Through both methods, the locations of neurons forming functional synaptic connections to 
single neurons can be revealed and mapped onto the spinal dorsal horn or the brain. LSPS 
combined with glutamate uncaging selectively activates neurons perisomatically, and spares 
axons de passage or distal dendrites. This ensures a sub-laminar mapping resolution.  
iii. Contactless activation of pain pathways 
A milestone in the application of optogenetics to pain research was the design of a mouse 
line expressing ChR2 on the terminals of its nociceptors (Nav1.8) (Daou et al., 2013). There 
are two main advantages to this strategy, namely: 1) the selective activation of nociceptors 
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by shining light through the skin; and 2) the isolation of the nociceptive input with reduced 
risk of activating touch-pathways upon handling of the animal. However, one caveat to this 
technique is that mice are generally moving, making it harder to attempt stimulating the 
nociceptors and produce sensitization by repeated stimulations to the nociceptors (Bonin 
and De Koninck, 2014). 
 
Viruses to assess the function of spinal neuronal populations  
Specific cell-ablation is another useful method to analyze the function of cells in a circuit. In 
addition to characterizing the electrophysiological changes in synaptic transmission, the 
phenotype provides a supplementary readout on the importance or not of such cell 
population in the circuit.  
i.  Diphtheria toxin (DT) 
In experimental biology, DT is frequently used to ablate cells. Two mechanisms can lead to 
cell death with DT. Either the human DT receptor is expressed in the target cell population, 
so that upon DT injection only cells expressing the receptor are ablated (Saito et al., 2001) or, 
the expression of DT fragment A (DTA) is triggered by Cre recombinase, expressed in a 
specific cell type (and thus leads to conditional induction of cytotoxicity). This method of 
conditional ablation with DTA has been exploited in several studies where the injection of DT 
ablated specifically Cre+ cells upon expression of the toxin (Brockschnieder et al., 2006; Duan 
et al., 2014; Bourane et al., 2015). Such loss-of-function experiments revealed the 
contribution of a subpopulation of inhibitory and excitatory neurons to the regulation of pain 
(Duan et al., 2014; Foster et al., 2015) or itch circuits (Bourane et al., 2015).  
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I  Abstract 
 
Diminished synaptic inhibition in the superficial dorsal horn (sdh) is believed to underlie 
several chronic pain syndromes. Here, we describe electrophysiological and behavioral 
changes in a genetic mouse model of diminished synaptic inhibition in the spinal cord, i.e. in 
mice that lack a major GABAA receptor (GABAAR)  subunit (2) from the spinal cord and the 
spinal terminals of peripheral sensory neurons (hoxb8-gabra2-/- or, short, hoxb8α2-/- mice). 
We first characterized changes in GABAergic inhibition in the sdh where 2-GABAARs are 
abundantly expressed. These experiments were done on a vGAT::ChR2 transgenic 
background which allowed optogenetic activation of inhibitory neurons in spinal cord slices. 
In hoxb8α2-/- mice, light-evoked GABA-IPSC amplitudes were reduced by about 50% 
compared to α2fl/fl mice with no significant change in their decay kinetics. Despite the 
reduction in GABAergic synaptic inhibition, hoxb8α2-/- mice did not show behavioral 
sensitization to acute painful stimulation, suggesting the presence of a compensatory 
plasticity mechanism. No significant changes were found in the amplitudes of glycinergic 
IPSCs or of membrane currents evoked by extracellular application of GABA. No significant 
differences were found for the decay kinetics of GABA-IPSCs. We also did not find significant 
changes in the amplitudes of sensory afferent evoked excitatory postsynaptic currents 
(EPSCs). By contrast, we found increased bicuculline-sensitive (GABAAR mediated) tonic 
membrane currents in hoxb8α2-/- mice. Furthermore, in immunohistochemical experiments, 
significant increases in serotonin immunoreactivity and in the expression of the serotonin 
producing enzyme tryptophan hydroxylase (TPH2) were found. Both the increases in tonic 
GABAergic currents and in serotonergic input to the spinal cord may on a behavioral level 
compensate for the loss of synaptic GABAergic inhibition and may explain why hoxb8α2-/- 
mice lack a pronociceptive phenotype. We also used the hoxb8α2-/- mice to investigate the 
role of α2-GABAARs in the analgesic effects of HZ-166, a less sedating benzodiazepine-site 
agonist with reduced activity at α1-GABAARs. In hoxb8α2-/- mice, HZ-166 had almost 
completely lost its analgesic action, and, in line with this observation, its effects on the 
kinetics of GABA-IPSCs were significantly reduced. These results confirm the important role 
of α2-GABAARs in spinal nociceptive control. Diminished α2-GABAAR mediated inhibition may 
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be compensated by increases in tonic GABAergic inhibition or in the serotonergic input to the 
spinal cord. 
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II Introduction 
 
The spinal cord serves as first relay center for incoming sensory and nociceptive signals from 
the periphery. Nociceptive afferents preferentially terminate in the sdh laminae I and II (LI, 
LII, respectively) where nociceptive signals undergo extensive processing and modulation by 
a network of local interneurons and by input from descending excitatory and inhibitory fiber 
tracks (Snider and McMahon, 1998; Basbaum et al., 2009). It is widely accepted that 
weakening of synaptic inhibition in the sdh laminae (LI-LII) contributes to chronic pain 
symptoms, including hyperalgesia and allodynia (De Koninck, 2007; Sandkuhler, 2009; Kuner, 
2010; Zeilhofer et al., 2012a). Fast inhibitory neurotransmission in the spinal dorsal horn is 
mediated by GABA and/or glycine. In the sdh, particularly in LII, most inhibitory neurons are 
purely GABAergic (Todd and Spike, 1993; Zeilhofer et al., 2012b) whereas most inhibitory 
neurons of the deep dorsal horn release GABA and glycine. GABAARs are heteropentamers, 
and in the central nervous system (CNS) the most prevalent subunit composition is 2α (α1-5), 
2β (β1-3) and 1γ (γ1-3) (Olsen and Sieghart, 2008). In the spinal termination area of 
nociceptors, GABAARs containing the α2 subunit (α2-GABAARs) are the most abundant 
subtype (Bohlhalter et al., 1996). These receptors are expressed presynaptically on the 
terminals of sensory fibers and postsynaptically on central neurons of the dorsal horn 
(Persohn et al., 1991; Bohlhalter et al., 1996). A growing body of evidence suggests that α2-
GABAARs are important contributors to spinal benzodiazepine-mediated antihyperalgesia 
(Knabl et al., 2008; Knabl et al., 2009; Paul et al., 2014; Ralvenius et al., 2015). In a previous 
study, our group has shown that hoxb8α2-/- mice, which lack spinal α2-GABAARs present no 
behavioral sensitization in acute pain tests (Paul et al., 2014) suggesting the presence of 
efficient compensatory mechanisms. In the present study we identified increased tonic 
GABAergic membrane currents and increased serotonergic innervation of the spinal cord as 
possible compensatory mechanisms.   
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III  Aim of this chapter  
 
A previous study in our group showed that mice lacking spinal 2-GABAAR showed no 
enhanced pain sensitization following acute pain tests when compared to control animals.  
In this chapter, I present an electrophysiological characterization of synaptic and 
extrasynaptic receptors in the 2fl/flhoxb8cre;vGAT::ChR2 mice (referred to as 2fl/fl for 
control animals and hoxb82-/- for conditional knock-out) to reveal potential compensatory 
mechanisms that may emerge in order to balance the diminished synaptic inhibition in the 
hoxb82-/- mice. In parallel, I addressed the role of 2-GABAAR in the antihyperalgesic or 
analgesic effects of HZ-166, a less sedating BDZ with reduced activity on 1-GABAARs.  
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IV  Material and methods 
 
Animals  
Animal procedures were approved by the Cantonal Veterinary Office (licenses 126/2012, 
74/2013, 86/2013, 031/2016). Two strains of GABAAR mutated mice (3-4 weeks old) of either 
sex were used for the different electrophysiology experiments. 2fl/fl;hoxb8cre-;vGAT::ChR2-
YFP (α2fl/fl) and 2fl/fl;hoxb8cre+;vGAT::ChR2 (hoxb82-/-) double transgenic mice were 
obtained by crossing 2fl/fl transgenic mice (Witschi et al., 2011) with double transgenic 
hoxb8cre+;vGAT::ChR2 BAC transgenic mice (Witschi et al., 2010; Zhao et al., 2011). Global α2 
knock-out (α2-/-) mice were used for control stainings. 
Drugs and chemicals 
D(-)-2-amino-5-phosphopentanoic acid (APV) was used during spinal cord slicing at a 
concentration of 50 µM. In electrophysiological experiments GABA, HZ-166 and strychnine 
hydrochloride were dissolved in extracellular solution to a final concentration of 50 µM, 10 
µM and 0.5 µM respectively. (-)-Bicuculline methochloride was used at a concentration of 20 
µM. In some cases, 20 µl of 20 mM stock solution NBQX (200 µM) was directly added into the 
bath at the end of the recording and served as a control to ensure the recorded current was 
excitatory. For behavioral testing, HZ-166 was suspended in 0.5% methyl cellulose and 
injected with 16mg kg-1 body weight (Paul et al., 2014). All chemicals were purchased from 
Tocris (Germany).  
Electrophysiology and optogenetic stimulation 
Light-induced inhibitory post-synaptic currents (IPSCs), exogenous GABA-evoked membrane 
currents and light-evoked excitatory post-synaptic currents (EPSCs) were recorded using a 
double patch-clamp EPC 9 amplifier controlled with Patchmaster acquisition software (both 
HEKA Elektronik Dr. Schulze GmbH, Germany). Activation of the neurons by blue light was 
applied either directly to the cell soma by the UGA-40 GEO laser system (473 nm, 1 s, spot 
size 10 µm, 715.9 mW/mm2, RAPP OptoElectronic, GmbH) to check for the presence of a 
photocurrent in the recorded cell, or in wide-field mode with a monochromator Polychrome 
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V (473 nm, 4 ms, Field of illuminations ± 200-300 µm, 2.7 mW, Tillvision, Thermo Fisher 
Scientific, USA) to evoke IPSCs.  
Spinal cord slice preparation and electrophysiological recordings 
Transverse 400 µm thick slices of the lumbar spinal cord slices were prepared from 20-30 
days old mice of either sex. Slices were cut in ice-cold solution with the following composition 
in mM (Dugue et al., 2009): 130 K-gluconate, 15 KCl, 0.05 EGTA, 20 HEPES and 25 glucose 
titrated to pH 7.4 with KOH and supplemented with 50 µM D-APV to prevent glutamate 
excitotoxicity. Slices were then kept 30 minutes for recovery in a solution containing (in mM) 
225 D-Mannitol, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 0.8 CaCl2 and 8 MgCl2 and 25 glucose 
(37°C, bubbled with 95% O2, 5% CO2). In a final step, slices were transferred to an artificial 
cerebrospinal fluid (aCSF), also known as extracellular solution with the following 
composition (in mM): 120 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 5 HEPES, 1 MgCl2, 2 CaCl2 
and 14.6 glucose. Slices were transferred to a recording chamber and continuously perfused 
with aCSF equilibrated with 95% O2, 5% CO2 at a flow rate of 1ml min-1. Neurons in the 
superficial dorsal horn (sdh, LI, II <150 µm from the dorsal margin) were visually identified 
with an iXON Ultra camera (Andor Technology, Belfast, UK) and using the infrared gradient 
contrast equipment of the microscope (Zeiss Examiner. A1, Göttingen, Germany). Whole-cell 
voltage-clamp recordings were performed at room temperature at a holding potential of -60 
mV from presumed excitatory neurons. For the recording of inhibitory postsynaptic currents 
(IPSCs), patch pipettes were prepared from borosilicate glass capillaries and had an open tip 
resistance of 3-5 MΩ. Recording pipettes were filled with an internal solution containing (in 
mM): 120 CsCl, 2 MgCl2 + 6 H20, 10 HEPES, 0.05 EGTA, 2 MgATP, 0.1 NaGTP. CsCl was used to 
block GABAB receptor-mediated K+ currents and Qx-314 (5mM) to block voltage-activated 
Na+ channels in the recorded cell. Excitatory postsynaptic currents (EPSCs) were recorded 
using a K-gluconate based internal solution containing (in mM): 130 K-gluconate, 20 KCl, 0.05 
EGTA, 2 MgCl2+6H20, 2 MgATP, 0.1 NaGTP, 10 Na Hepes, 5 Qx-14. 
Access resistance of the cell was continuously monitored by giving short hyperpolarizing 
steps (-5 mV) between the synaptic light-stimulations or before and after application of the 
drug in the case of tonic currents. Recordings were discarded if the access resistance 
changed > 20% or if recovery to baseline currents before GABA application was less than 85-
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90% in the case of tonic currents. All recordings were performed on excitatory neurons 
(excepted where stated) of the sdh (LI/II). To discriminate between excitatory and inhibitory 
neurons, we applied a one second blue light pulse on the soma of the recorded neuron using 
laser light-stimulation. Cells showing no photocurrents (i.e. excitatory neurons) were kept for 
experiments. All electrical signals were sampled either at 20 KHz (light-induced GABAergic 
currents) or 5 KHz (tonic currents) and filtered at 2.9 kHz. Data was analyzed using IgorPro 
(WaveMetrics, Inc.,USA).  
We elicited light-induced GABAergic currents at a frequency of 4 stimulations per minute 
using wide-field illumination of the dorsal spinal cord (473 nm, 4ms, 20.4 mW/mm2). Steady-
state GABAergic currents were achieved after 2-3 minutes of continuous strychnine 
application. After 5 minutes baseline recording, HZ-166 was co-applied for 7-15 minutes. 
Finally, bicuculline (antagonist of GABAARs) was bath-applied in addition to strychnine 
(antagonist of glycine receptors) to inhibit the GABAAR-mediated current and thus confirm 
the nature of the current.  
Exogenous GABA-evoked membrane currents were also studied. In this approach, we 
recorded 1 minute baseline. GABA was then bath applied until a steady-state was reached, 
usually 1 minute after application. Subsequently, HZ-166 was co-applied with GABA until we 
reached a second steady-state. Finally, bicuculline was added to inhibit the remaining 
GABAAR-mediated current and thus confirm the recording of a GABAergic current.  
Excitatory postsynaptic currents (EPSCs) were recorded from undefined neurons chosen from 
a region of the sdh with strong mCherry expression (i.e. region where AAV1:ChR2:mCherry 
infected primary afferent fibers showed strong mcherry fluorescence). We stimulated the 
terminals using a 4 ms light pulse of blue light every ten seconds and recorded light-evoked 
EPSCs. In a final step, we injected NBQX (20mM) into the bath to eliminate the excitatory 
current. 
Virus injection  
AAV1-ChR2:mCherry virus (approximately 2 µl each side) was bilaterally injected in the sciatic 
nerve of  15-28 days old 2fl/fl and hoxb82-/- mice. One week post-injection, mice were 
decapitated and acute spinal cord slices were prepared for whole-cell recordings following 
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the same procedure as described previously with none injected mice (see Spinal cord slice 
preparation and electrophysiological recordings). Infected cells of the dorsal root ganglions 
(DRGs) at lumbar segment L4 were observed under the two-photon microscope and the 
soma diameter of the cells (72 cells from 3 animals) was determined after acquiring a z-stack 
image using the 2-axis average diameter method (Scroggs and Fox, 1992). 
Behavioral testing  
All behavioral experiments were performed in 8-10-week-old female and male mice. 
Experiments were conducted by an experimenter blinded either to the genotype of the mice 
and to their treatment with drug or vehicle.  
Formalin (4%, 20 μl) was injected subcutaneously into the dorsal surface of the left hind paw. 
Licking bouts of the injected paw were counted for 60 minutes in 5 minutes intervals starting 
immediately after formalin injection (Hösl et al., 2006). HZ-166 (16 mg kg-1 body weight) was 
given intraperitoneally (i.p) 1 hour before formalin (4%, 20 µl) into the hind paw and licking 
bouts of the injected paw were measured in the same way as previously described. 
Mechanical withdrawal thresholds and thermal withdrawal latencies were assessed using an 
electronic von Frey anesthesiometer and Hargreaves test apparatus with a temperature 
controlled glass platform (30°C) (both from IITC, Woodland Hills, CA). Responses to noxious 
cold were determined following the protocol by (Brenner et al., 2012) using a 5 mm thick 
borosilicate glass platform and applying dry ice below the paw of the animal with a 5 ml 
syringe. Pin prick technique was performed using a blunt syringe that does not perforate the 
skin, as described in Foster et al. (2015). Six measurements were made for each time point 
per animal for both mechanical and heat tests. 
Immunohistochemistry 
Adult 2fl/fl and hoxb82-/- mice were injected i.p with 0.25 ml pentobarbital and perfused 
through the ascending aorta with 50 ml ice-cold ACSF at RT for 2 minutes (Paul et al., 2012). 
Spinal cord and brain were then removed and fixed in cold 4% PFA for 90 minutes before 
being transferred to 30% sucrose in phosphate buffer saline (PBS) at 4°C overnight for 
cryoprotection (Notter et al., 2014). Tissue was cut coronally at 20 µm from frozen blocks 
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into cryosections and mounted onto Superfrost Plus microscope slides (Thermo Scientific, 
Zurich, Switzerland). Immunohistochemistry was performed on tissue  
The distribution of the GABAAR 2 subunit, vesicular glutamate transporter 1-3 (VgluT 1-3), 
serotonin (5-HT) and tryptophan hydroxylase 2 (TPH2) was visualized on 20 µm-thick lumbar 
spinal cord cryosections by Diaminobenzidine tetrahydrochloride (DAB, Sigma, St. Louis, MO) 
staining. In brief, sections were incubated overnight at 4°C in primary antibodies diluted in 
Tris triton (pH 7.4) containing 4% NGS and 0.2% Triton X-100. The dilutions of antibodies 
were: 2 subunit, 1:1000 (in house; Paul et al., 2012); VgluT1, 1:12’000 (Synaptic systems); 
VgluT2 (Synaptic systems), 1:5000; VgluT3 1:3000 (Chemicon); 5HT, 1:500 (Immunostar, 
France); TPH2, 1:500 (Novus Biologicals). Sections were washed three times with PBS and 
stained with avidin-biotin complex (ABC) immunoperoxidase method according to 
specifications of the manufacturer. DAB hydrochloride, diluted 0.05% in Tris saline (pH 7.7) 
with 0.01% hydrogen peroxide was used as a chromogen. The staining reaction was carried 
out for 3-5 minutes at room temperature and stopped by transferring the sections to ice-cold 
buffer. Sections were air-dried, dehydrated with an ascending series of ethanol and xylene 
and coverslipped with Eukitt (Erne Chemie, Dallikon, Switzerland) (Paul et al., 2012).  
Image J was used for quantifying the intensity of the staining. For this ROIs were drawn in the 
superficial and deep spinal dorsal horn and the intensity mean value was measured. 
Background mean intensity value was subtracted from the mean intensity values of our ROIs. 
Data analysis 
For statistical analyses, amplitude and kinetic averages of light-induced IPSCs were calculated 
from 10 consecutive current traces (2.5 minutes) in control, strychnine, and strychnine with 
HZ-166 conditions (5.5 minutes after drug application). A weighted tau with a double 
exponential fit was used to measure the decay kinetics of the light-evoked currents 
(Labrakakis et al., 2014). 
For tonic current measurement, an all-points histogram was plotted for a 30 seconds period 
immediately preceding drug application (i.e., baseline condition) and finishing drug 
application (drug was applied for 5-7 minutes), respectively. A Gaussian was fitted to the side 
of the distribution not skewed by synaptic events, and the peak was used to determine the 
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mean baseline holding current required to maintain the voltage of the cell at -60 mV. Tonic 
currents in the presence of bicuculline were determined by repeating the fitting procedure 
after drug application and measuring the difference in mean baseline holding currents before 
and after application of bicuculline. Statistical significance between the two genotypes was 
analyzed using an unpaired Student’s t test.  
To measure the change in amplitude induced by evoked-GABA, we subtracted a 30 seconds 
period of GABA-evoked current amplitude from 30 seconds period of baseline current 
recorded before GABA application. We proceeded similarly with HZ-166-induced potentiation 
of GABA currents, and subtracted the HZ-166-induced current amplitude to baseline. 
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V Results 
 
Deletion of 2-GABAARs in the spinal cord 
We used the hoxb8cre::2-/- mice (Paul et al., 2014), in which the 2-GABAAR subtype was 
ablated from dorsal root ganglia (DRGs) and the spinal cord up to cervical segment C4, 
henceforth known as the hoxb82-/- mice. In order to confirm the absence of 2-GABAAR 
subtypes from the spinal cord in these mice, we performed immunocytochemistry staining 
on tissue from 2fl/fl and hoxb82-/- mice against the 2 subunit and quantified the intensity 
of the staining by measuring the mean grey values in the superficial and deep dorsal horn 
(Figure 1A). The staining intensity of the 2 subunit in hoxb82-/- mice was significantly 
reduced as compared to 2fl/fl, and was virtually identical to that of global 2 knock-out (2-/-
) mice indicating that no 2 subunit expression remained on a spinal level in these mice 
(Figure 1B). 
 
Figure 1. Absence of α2-GABAAR in the spinal cord of hoxb8α2-/- mice. A, Spinal dorsal horn tissue 
immunocytochemistry against the α2 subunit in α2fl/fl (left), hoxb8α2-/- (middle) and global α2-/- mice (right). B, 
Quantification of immunoperoxidase intensities in a staining against α2 shows 76% intensity reduction in the 
hoxb8α2-/- mice compared to α2fl/fl (mean 24.17±0.92 for α2fl/fl; mean 5.7±0.5 for hoxb8α2-/-, and 4.7±0.5 for α2-
/-, unpaired Student’s t-test *** p<0.0001, N=2 mice, n=8 slices/mouse).  
Hoxb82-/- mice exhibit normal nociceptive response thresholds 
The 2-GABAAR subtypes are highly expressed in the spinal cord dorsal horn (Paul et al., 
2012). We sought to assess whether the ablation of this subtype from the spinal cord would 
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influence nociceptive responses in naïve mice. To this end, we employed the von Frey test of 
mechanical stimulation, Hargreaves’ plantar test for heat sensitivity, pin prick test of noxious 
mechanical stimulation and cold allodynia tests, and analyzed the response thresholds in the 
2fl/fl, hoxb82-/- and 2R/R mice, which carry a point-mutation of histidine to arginine 
residues (H→R) on the 2-benzodiazepine binding site, rendering them insensitive to most 
BDZ (Figure 2A-D). The latter mice were included as they were used in a subsequent test to 
demonstrate the contribution of spinal 2-GABAAR to BDZ-mediated antihyperalgesia. In all 
four tests, the three genotypes did not show any differences in the pain readouts. 
 
Figure 2. Lack of differences in acute nociception in hoxb8α2-/- mice compared to control mice. Response 
thresholds of naïve α2fl/fl, hoxb8α2-/- and α2R/R mice. A, mechanical paw withdrawal thresholds for von Frey 
(α2fl/fl: 4.6±0.2 g; hoxb8α2-/-: 4.7±0.2 g; α2R/R: 4.4±0.2 g), thermal withdrawal latencies for Hargreaves’ (α2fl/fl: 
10.80±0.8 s; hoxb8α2-/-: 13.5±2.1 s; α2R/R: 11.9±0.7 s), paw response frequency for pin prick test (α2fl/fl: 
93.3±3.1%; hoxb8 α2-/-: 91.7±3.7%; α2R/R: 95±3.3%), and cold allodynia testing (α2fl/fl: 7.4±0.3 s; hoxb8α2-/-: 
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6.5±0.5 s; α2R/R: 7.7±0.4 s). Each data point indicates individual mouse. Error bars indicate mean ± SEM, n=5 
mice for all genotypes. p > 0.05, one-way ANOVA followed by Bonferroni post hoc test. 
Characterization of light-evoked activity in dorsal horn inhibitory cells of vGAT::ChR2 mice 
In order to assess the impact of spinal 2-GABAAR ablation on spinal inhibitory 
neurotransmission, we combined electrophysiological whole-cell patch-clamp recordings and 
optogenetics in spinal cord slices. To this end, we decided to cross the vGAT::ChR2-YFP allele 
(Zhao et al., 2011) into double transgenic 2fl/fl;hoxb8cre mice to allow activation of 
inhibitory neurons by exposure to blue light. Before doing experiments in hoxb82-/-
;vGAT::ChR2 mice, we characterized photocurrents, light-induced action potential firing and 
light-induced synaptic transmission in the spinal cord slices of the vGAT::ChR2 transgenic 
mice. In this mouse line, channelrhodopsin 2 (ChR2) is fused to a fluorescent reporter (YFP) 
and expressed under the transcriptional control of the vesicular GABA transporter (vGAT) 
gene, which is expressed in all inhibitory neurons, including glycinergic neurons. YFP 
fluorescence in vGAT::ChR2 mice spinal cord slices was expressed across the entire spinal 
cord (Figure 3A, bottom). To record photocurrents, neurons in LII were held at a potential of -
70 mV and the soma of the recorded neuron was exposed to blue light for 1 s or 4 ms (Figure 
3A, top). About half of the recorded neurons responded to light stimulation with a 
photocurrent. One second blue light exposure induced a fast activating inward current that 
partially inactivated during prolonged light exposure and that rapidly returned to baseline 
upon off-set of light stimulation (Figure 3B, top). Shorter light exposure (4 ms) led to 
photocurrents of similar amplitude but of shorter duration (Figure 3C, top). The same light 
stimuli were then applied to the same neurons in current-clamp mode. One second light 
exposure led to tonic action potential firing, which is a characteristic of inhibitory neurons 
(Figure 3B, bottom), and to a single action potential in response to shorter (4 ms) light 
stimulation (Figure 3C, bottom). All light-evoked IPSC were completely blocked by a 
combination of strychnine and bicuculline (see Chapter 2, Part B).  
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Figure 3. Optogenetic characterization of inhibitory dorsal horn neurons. A, Top, schematic depicting the light 
pulse (473, 4 ms) applied to the dorsal horn of acute spinal cord slices from vGAT::ChR2-YFP BAC transgenic 
mice. The recording pipette is represented on superficial dorsal horn. Bottom, Distribution of the ChR2-YFP 
fluorescence in a horizontal lumbar spinal cord slice of a vGAT::ChR2 mouse (scale bar 500 µm). B, Top, Partially 
desensitizing photocurrent recorded from a lamina II (LII) inhibitory interneuron evoked by a 1 s light exposure. 
Bottom, The same light exposure evoked a train of action potentials in current clamp mode. C, Top, Short 
photocurrent evoked by a 4 ms light stimulation. Bottom, Single action potential evoked by the same 4 ms light 
pulse, recorded in current clamp configuration. 
Reduced synaptic currents but unchanged membrane currents evoked by exogenous 
application of GABA in the hoxb8α2-/- mice  
We then continued with the analysis of hoxb8α2-/-;vGAT::ChR2 transgenic mice and 
compared light evoked inhibitory neurotransmission in hoxb8α2-/-;vGAT::ChR2 and 
α2fl/fl;vGAT::ChR2 mice. To this end, we applied 4 ms light (blue bar, λ=473 nm, power 
density: 20.4 mW/mm2) on acute spinal cord slices and first recorded light-evoked total IPSCs 
(i.e., mixed GABAergic and glycinergic currents). The amplitude values of the total IPSCs 
(mixed GABAergic and glycinergic) between 2fl/fl and hoxb8α2-/- mice were statistically not 
significant, however, there was a trend towards lower amplitudes in hoxb8α2-/- mice 
compared to α2fl/fl mice (α2fl/fl: -1054 ± 200 pA, n=8 cells and hoxb8α2-/-: -558 ± 154 pA n=10 
cells, p=0.06, unpaired Student’s t-test) (Figure 4A). We also analyzed possible changes in the 
amplitude of light-evoked glycinergic IPSCs in α2fl/fl and hoxb8α2-/- mice. To this end, we 
subtracted the amplitude values of light-evoked GABA-IPSCs (see Figure 4C) from the 
amplitudes of the total IPSCs. Differences in glycinergic IPSC amplitude between α2fl/fl and 
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hoxb8α2-/- were also not statistically significant (α2fl/fl: -633±155 pA, n=8 cells and hoxb8α2-/-: 
-374 ± 133 pA n=10 cells, p=0.22, unpaired Student’s t-test) (Figure 4B). We recorded GABA-
IPSCs from presumed excitatory photocurrent negative neurons in the presence of strychnine 
to block the glycinergic current component (Figure 4C). We found that light-evoked GABA-
IPSCs were 50% smaller in amplitude in the hoxb8α2-/- mice (-151.7±30.4 pA, n=13 cells) 
compared to α2fl/fl mice (-353±65.2 pA, n=17 cells) (Figures 4C, D). Time constants of light-
evoked IPSCs in hoxb82-/- mice were statistically not different compared to those from 2fl/fl 
mice (2fl/fl: 65.0±8.2 ms, n=17 cells; hoxb82-/-: 83.4±9.0 ms, n=13 cells, p=0.14, unpaired 
Student’s t-test, Figure 4E). 
Although α2-GABAARs are primarily located at synapses, the ablation of the α2 subunit might 
have an impact on the number of “reserve” receptor at extrasynaptic sites. To address this 
possibility, we recorded membrane currents evoked by extracellular (bath) application of 
GABA (50 µM) (Figure 4F). These currents reached similar amplitudes in hoxb8α2-/- mice and 
in α2fl/fl mice (-172.2±42.4 pA, n=7 cells, and -143.4±37.4 pA, n=7 cells, in hoxb8α2-/- and 
α2fl/fl mice, respectively) (Figure 4G). 
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Figure 4. Reduced synaptic currents but unchanged membrane currents evoked by exogenous application of 
GABA in the hoxb8α2-/- mice. A, Graph showing no statistical significance in total light-evoked IPSC amplitudes 
between α2fl/fl and hoxb8α2-/- mice (α2fl/fl: -1054±200 pA, n=8 cells from N=6 mice and hoxb8α2-/-: -558±154 pA 
n=10 cells from N=9 mice, p=0.06, unpaired Student’s t-test). B. Graph showing no statistical difference in 
glycinergic IPSC amplitude values between α2fl/fl and hoxb8α2-/- mice (α2fl/fl: -633±155 pA, n=8 cells from N=6 
mice and hoxb8α2-/-: -374±133 pA, n=10 cells from N=9 mice, p=0.22, unpaired Student’s t-test). C, Statistics 
showing a significant amplitude reduction of light-evoked GABA-IPSCs in hoxb8α2-/- mice compared to α2fl/fl 
mice (α2fl/fl: -353±65.2, n=17 cells from N=14 mice, and hoxb8α2-/-: -151.7±30.4 n=13 cells from N=12 mice, 
*p=0.02 unpaired Student’s t-test). Error bars indicate mean±SEM. D, Example traces of light-evoked GABA-
      
59 
IPSCs (4 ms light pulse) recorded in the presence of strychnine (0.5 µM), an antagonist of glycine receptors. 
Hoxb8α2-/- mice show reduced GABAergic IPSC amplitudes compared to α2fl/fl. Decay kinetic (tau) values were 
obtained by using a double exponential fit, here shown in red. E, Scatter plot shows no significant change in 
baseline tau values between the two genotypes (α2fl/fl: 65±8.2 ms; hoxb8α2-/-: 83.4±9 ms, p=0.14, unpaired 
Student’s t-test). F, Example traces of GABA-evoked membrane currents (50 µM GABA) in excitatory neurons of 
α2fl/fl and hoxb8α2-/- mice. G, No change in GABA-evoked membrane current amplitudes is observed between 
the two genotypes (α2fl/fl: -143.4±37.4 pA and hoxb8α2-/-: -172.2±42.4 pA, n=7 cells from N=5 mice, p=0.62, 
unpaired Student’s t-test). 
Extrasynaptic GABAARs also underlie part of the tonic membrane currents present in a 
subpopulation of dorsal horn neurons (for review, see Farrant and Nusser, 2005). To test 
possible differences in such tonic membrane currents, we performed again whole-cell patch-
clamp recordings again from presumed excitatory neurons and bath-applied bicuculline (20 
µM) after 5 minutes of baseline current recording (Figure 5A left panel). Cells from hoxb82-/- 
mice had larger holding currents under baseline conditions compared to neurons from 2fl/fl 
mice (Figure 5B, left panel, 2fl/fl: -27±2.0 pA, n=9 cells; hoxb82-/-: -41.2±6.0 pA, n=7 cells). 
In addition, we found that the bicuculline sensitive component of these tonic currents was 
larger in hoxb82-/- mice than in 2fl/fl mice (Figure 5B, right panel, α2fl/fl: -0.3±1.1 pA; 
hoxb82-/-: -10.0±3.9 pA).  
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Figure 5. Increased tonic inhibition in hoxb8α2-/- compared to control animals. A, Example traces of tonic 
currents in α2fl/fl and hoxb8α2-/- mice before and after application of bicuculline (20 µM). Grey and red bars 
indicate the areas that were analyzed for the all-point histograms of control and bicuculline conditions, 
respectively. The all-point histograms follow a Gaussian distribution and depict the amplitude scattering in a 30s 
range analyzed from the current recorded in control and bicuculline conditions, respectively. After application 
of bicuculline, the amplitude range shifts to higher values and the noise (represented by the width of the curve) 
becomes smaller in hoxb8α2-/- compared to α2fl/fl. B Left, Plot showing significantly higher holding currents in 
baseline conditions (before application of bicuculline) in hoxb8α2-/- mice (-41.2±6.0 pA, n=7 cells) compared to 
α2fl/fl mice (-27±2.0 pA, n=9 cells), *p=0.03, unpaired Student’s t-test. Right, After application of bicuculline, 
hoxb8α2-/- mice show a larger shift in holding current amplitudes compared to α2fl/fl mice (α2fl/fl: 0.3±1.1 pA, n=9 
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cells from N=7 mice and hoxb8α2-/-: -10.0±3.9 pA, n=7 cells from N=4 mice, *p=0.02, unpaired Student’s t-test. 
Error bars indicate mean±SEM. 2fl/fl: hoxb82-/-:  
 
Hoxb8α2-/- mice show unaltered excitatory input from nociceptors compared to α2fl/fl mice  
Since transmitter release from nociceptive fibers is under control of presynaptic GABAARs 
that contain α2 subunits (Witschi et al., 2011), we investigated possible changes in the 
excitatory neurotransmission between primary afferent C-fibers and dorsal horn second 
order neurons. To allow selective activation of input from nociceptive primary sensory fibers 
we employed again optogenetics. Bilateral injections of CAG-AAV1 ChR2-mCherry virus were 
made into the sciatic nerve of naïve α2fl/fl and hoxb8α2-/- mice. These injections led to the 
infection of dorsal root ganglion cells of the lumbar segment L4 (Figure 6A). Analysis of the 
soma diameter of the infected DRG neurons indicated that the great majority of infected cells 
had a soma diameter of approximately 20 µm (Figure 6B, n=72 cells from N=3 mice) 
suggestive of nociceptive neurons. Seven days after virus injection, we prepared transverse 
spinal cord slices of the L4 segment for electrophysiological recordings from unidentified LII 
cells. After establishing whole-cell recordings we stimulated the dorsal horn with blue light (λ 
=473 nm, light exposure: 4ms, power density: 20.4 mW/mm2) recorded light-evoked EPSCs 
(Figure 6C, middle panel). No statistically significant difference was observed between 
genotypes with regards to amplitude (α2fl/fl: -108.2±34.7 pA; hoxb82-/-: -117.8±41.3 pA, 
p=0.85 unpaired Student’s t-test) and decay kinetics (α2fl/fl: 7.6±1.6 ms; hoxb82-/-: 8.5±0.9 
ms, p=0.68 unpaired Student’s t-test) or success rate (α2fl/fl: 94.2±3.4%, hoxb82-/-: 
99±1.00%, p=0.20 unpaired Student’s t-test). N=10 and 11 cells for α2fl/fl and hoxb82-/- mice, 
respectively (Figure 6C, bottom). A trend was seen for enhanced synaptic transmission 
between primary nociceptive fibers and second order neurons, which would be in line with 
reduced GABAergic inhibition of transmitter release from spinal nociceptor terminals.  
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Figure 6. Excitatory input from primary nociceptive fibers onto dorsal horn second order neurons remains 
unaffected in the hoxb8α2-/- mice. A, Depiction of the CAG-AAV1 ChR2-mCherry injection into the sciatic nerve 
of α2fl/fl or hoxb8α2-/- mice. Z-projection two-photon image of virus-infected ganglion cells in DRGs of lumbar 
segment L4. B, Histogram showing the soma diameter ranges of the infected ganglion cells within the DRGs 
which could be fit by a Gaussian function. Average diameter: 20.9±0.4 µm; n=72 cells from N=3 animals. C, 
Fluorescence and IR images of LII (i.e. regions of interest) in acute spinal cord slices prepared from nerve-
injected mice. The fluorescence image shows punctate mCherry expression on terminals of primary afferent 
fibers of the infected DRG cells. Example traces from the two genotypes showing the average (black) of 7 (α2fl/fl) 
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and 10 (hoxb8α2-/-) EPSCs (grey) after 4 ms blue light exposure of primary afferent terminals. D, Statistical 
comparisons of amplitude, success rate and tau show no differences between α2 fl/fl and hoxb8α2-/- (α2fl/fl: n=11 
cells and hoxb8α2-/-: n= 10 cells, p=0.9; 0.3, and 0.7 for amplitude, success rate and tau, respectively, unpaired 
Student’s t-test). Error bars indicate mean±SEM. 
Enhanced serotonergic input to the spinal dorsal horn of hoxb8α2-/- mice 
Up to this point, the only finding that could potentially explain the absence of a nociceptive 
phenotype in hoxb8α2-/- mice is the increase in tonic GABAergic membrane currents. In order 
to extend our analyses to compensatory mechanisms in the glutamatergic system, we 
performed quantitative RT-PCR measurements to investigate possible differences in the 
expression of vesicular glutamate transporters in the DRGs of hoxb8α2-/- and α2fl/fl mice. In 
wild-type mice we found high expression of VgluT1 and VgluT2 mRNA. VgluT1 and VgluT2 are 
mainly expressed in non-nociceptive and nociceptive DRG neurons, respectively. Only very 
low levels of VgluT3 were detected. When we compared expression levels in hoxb8α2-/- and 
α2fl/fl mice, we detected a small but statistically significant decrease in mRNA copies of 
VgluT2 by 17% in the hoxb8α2-/- mice as compared to α2fl/fl mice (Figure 7A, *p=0.04, N=4 
mice/genotype, mean±SEM). To assess possible related changes in protein expression, we did 
quantitative immunohistochemistry for the three VgluTs in spinal cord sections. We focused 
these analyses on the superficial and deep dorsal horn, the spinal termination area of 
primary nociceptors (Figures 7B, C). We found no differences in expression levels of VgluT2 
but a small increase in VgluT3 expression, which is unlikely to be biologically relevant.  
As a final step, we also quantified markers of serotonergic input and used antisera for 
serotonin and tryptophan hydroxylase 2 (TPH2) a marker enzyme for serotonergic terminals. 
In these experiments we found a highly significant increase immunoreactivity against both 
markers in hoxb8α2-/- mice compared to α2fl/fl (29%, 46%, and 28%, respectively) (Figure 7B, 
C). Because serotonergic input exerts antinociceptive actions in the spinal cord, this up-
regulation appears as a second possible compensatory mechanism possible explaining the 
absence of hyperalgesia in hoxb8a2-/-mice. 
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Figure 7. Reduced levels of VgluT2 mRNA in the dorsal root ganglia and enhanced levels of serotonin in the 
spinal cord of hoxb8α2-/- mice. A, mRNA copy numbers relative to β-actin of VgluT1-3 in the lumbar dorsal root 
ganglia of α2fl/fl and hoxb8α2-/- littermates. Significant reduction of VgluT2 mRNA in the DRGs of hoxb8α2-/- 
compared to α2fl/fl mice. VgluT1 (α2fl/fl: 0.04±0.003; hoxb8α2-/-: 0.03±0.002); VgluT2 (α2fl/fl: 0.1±0.007; hoxb8α2-
/-: 0.08±0.002); VgluT3 (α2fl/fl: 0.03±0.0005; hoxb8α2-/-: 0.002±0.0002) from a total of N=4 mice/genotype, 
*p=0.04 unpaired Student’s t-test. Error bars indicate mean±SEM. B. Quantification of immunoperoxidase 
intensities in stainings of VgluT1, VgluT2, VgluT3, 5-HT (N=4 mice) and TPH2 (N=2 mice) in α2fl/fl and hoxb8α2-/- 
mice from the superficial and deep dorsal horn (sdh, ddh). Histogram reveals significant increases in staining 
intensity against VgluT3 (sdh α2fl/fl: 6.4±0.50; hoxb8α2-/-: 8.3±0.62; *p=0.02), 5-HT (sdh α2fl/fl: 19.2±1.2; 
hoxb8α2-/-: 28.1±2.0 ***p<0.0001; ddh α2fl/fl: 17.3±0.8; hoxb8α2-/-: 28.6±2 ***p<0.0001), and TPH2 (sdh α2fl/fl: 
15.5±1.2; hoxb8α2-/-: 19.5±1.4 *p=0.03) in hoxb8α2-/- mice compared to α2fl/fl mice. For the other comparisons 
p>0.05, unpaired Student’s t-test. Error bars indicate mean±SEM. C, (Left), Schematic showing the spinal cord 
regions of interest that were considered for quantification of the immunoperoxidase intensity in stainings of 
VgluT1-3, 5-HT and TPH2 in Figure 7B (1, sdh; 2, ddh). (Right), Representative images showing one side of the 
superficial dorsal horn reveal increased levels of VgluT3, 5-HT and TPH2 in the dorsal horn of hoxb8α2-/- mice 
compared to α2fl/fl mice. 
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Potentiation of synaptic GABAAR currents and GABA-evoked membrane currents by HZ-166 is 
diminished in hoxb82-/- mice  
In a next set of experiments, we used the hoxb8α2-/- mice to analyze their role in 
benzodiazepine mediated antihyperalgesia in more detail. For these experiments, we chose 
the less sedating benzodiazepine site agonist HZ-166 which has reduced agonistic activity at 
α1-GABAARs. Before doing in vivo experiments with HZ-166 we verified its in vitro 
pharmacological profile in HEK 293 cells transiently transfected with different combinations 
of GABAAR subunits (α1β2γ2, α2β3γ2, α3β3γ2 and α5β2γ2). In agreement with previous 
publications (Rivas et al.2009), both potency and efficacy of potentiation by HZ-166 were 
higher for α3-GABAARs and α2-GABAARs than for α1-GABAAR and α5-GABAAR subtypes 
(Figure 8).  
 
 
Figure 8. Potentiating effects of HZ-166 on four HZ-166-sensitive GABAAR subtypes. GABA-evoked membrane 
currents were measured in HEK 293 cells transiently transfected with recombinant α1β2γ2, α2β3γ2,  α3β3γ2 
and α5β2γ2 GABAARs. Top panels, traces show current responses evoked by GABA before (light trace) and 
during application of saturating concentrations of HZ-166 (10 µM, dark trace). Bottom graph representing dose-
response curves of the four different GABAAR subtypes at increasing HZ-166 concentrations. GABA was applied 
at EC10 (1µM, 5µM, 8 µM, and 1µM for α1β2γ2, α2β3γ2, α3β3γ2 and α5β2γ2 GABAARs, respectively) for 6-10 s. 
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We then characterized the sensitivity of GABA-IPSCs to HZ-166 in slices taken from 2fl/fl and 
hoxb82-/- mice. We analyzed HZ-166 (10 µM) induced changes in the decay time constants 
(). After application of HZ-166, decay time constants of light-evoked GABAergic currents 
increased to 194.2±12% (n=17 cells) of control values in 2fl/fl mice while in hoxb82-/- mice 
they increased only to 157.1±12.3% (n=13 cells) (*p=0.04, unpaired Student’s t-test) (Figure 
9A). We also tested the sensitivity to HZ-166 of membrane currents evoked by exogenous 
GABA. We found that potentiation by HZ-166 was significantly reduced in hoxb82-/- mice 
relative to 2fl/fl mice (2fl/fl: 88.2±16.2%, n=7 cells; hoxb82-/-: 45.7±8.3%, n=7 cells, 
*p=0.04, unpaired Student’s t-test, Figure 9B). 
 
Figure 9. Diminished potentiation of GABAergic currents by HZ-166 in hoxb8α2-/- mice. A, Example traces of 
light-evoked GABAergic currents recorded in the presence of strychnine in α2fl/fl and hoxb8α2-/- mice before 
(black) and after (green) application of 10 µM HZ-166. Potentiation of the GABAergic currents by HZ-166 is 
significantly reduced in hoxb8α2-/- mice. Potentiation of GABAergic currents by HZ-166 in hoxb8α2-/- mice is 
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significantly diminished relative to α2fl/fl mice (n=17 and 13 for α2fl/fl and hoxb8α2-/- mice, respectively *p=0.04, 
unpaired Student’s t-test). B, GABA-evoked membrane currents after application of HZ-166 in α2fl/fl and 
hoxb8α2-/- mice, respectively. In hoxb8α2-/- mice, potentiation of GABA-evoked membrane currents by HZ-166 is 
significantly reduced compared to α2fl/fl mice. All GABA-evoked currents are blocked by bicuculline (bic, 20 µM), 
the antagonist of GABAARs (n=7 α2fl/fl and hoxb8α2-/-, *p=0.04, unpaired Student’s t-test).  
We then performed again behavioral experiments to test whether the decreased sensitivity 
of GABA-IPSCs to HZ-166 translated into altered analgesic properties of HZ-166 in a rodent 
pain model. We used the formalin test, a model of inflammatory pain (Dubuisson and Dennis, 
1977), in which 4% formalin is injected into one hind paw, and immediately afterwards 
nocifensive behavior (licking bouts directed to the injected paw) is quantified for 1 hour. We 
first checked if there were any differences in the number of formalin-evoked licking bouts 
between the genotypes. No such differences were found (Figure 10A). We then examined 
the analgesic effect of HZ-166 (16 mg kg-1, i.p.) in the three genotypes. As expected, HZ-166 
significantly reduced numbers of formalin-induced nocifensive reactions (assessed as time 
spent licking of the injected paw) in 2fl/fl mice. By contrast, hoxb82-/- mice and 2R/R, 
whose 2-GABAARs are insensitive to HZ-166 mice (Paul et al., 2014) did not show significant 
reductions in nocifensive behaviors after HZ-166 (Figure 10B).  
 
Figure 10. HZ-166-mediated antihyperalgesia is lost in α2 conditional knockout and global α2 point mutated 
mice. A, Plot depicting the sum of licking bouts directed to the ipsilateral hind paw in the formalin test 
quantified in 5 min intervals for 60 min in α2fl/fl, hoxb8α2-/- and α2R/R mice. No difference was observed (α2fl/fl: 
243±39.9; hoxb8α2-/-: 269.4±21.2; α2R/R: 227.8±36.9), p=0.7, one-way ANOVA F(2,12)=0.4 (N=5 mice) for the 
interaction treatment x genotype, followed by Bonferroni post hoc test. B, Licking bouts per five minutes in mice 
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pretreated with HZ-166 one hour before formalin injection. Statistical analysis, circles indicate individual mice, 
and error bars indicate mean±SEM (α2fl/fl:119.2±13; hoxb8α2-/-: 237.9±14.; α2R/R :194.2±24.1), *p < 0.05, one-
way ANOVA F (5,52)=3.9 (n=8, 10, 11, 7, 12 and 10 mice) for the interaction treatment × genotype, followed by 
Bonferroni post hoc test.  
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VI Discussion 
 
Several lines of evidence indicate that α2-GABAARs serve an important function in the control 
of spinal nociceptive circuits. Several studies have shown that specific activation (via positive 
allosteric modulation) of 2-GABAARs reduces pain sensitivities in a number of rodent pain 
models (Knabl et al., 2009; Ralvenius et al., 2015). Based on these results one would expect 
that ablation of 2-GABAARs from the spinal cord should lead to increased pain sensitivity or 
or even signs of spontaneous pain (Foster et al., 2015). However, a study showed that mice 
lacking 2-GABAARs (hoxb82-/- mice) from the spinal cord showed no increased sensitivity 
to acute noxious mechanical and thermal stimuli (Paul et al., 2014). This could indicate the 
presence of potential compensatory mechanisms at the cellular and/or molecular level, 
which would be involved in countering the loss of inhibitory synaptic transmission. Revealing 
such mechanisms would be useful for novel drug-development strategies in countering 
chronic pain. 
In the present study, we have examined the functional consequences of deletion of the 
GABAAR α2 subunit from the spinal cord on the cellular and behavioral level. We first verified 
again that hoxb82-/- mice are indeed devoid of 2-GABAARs in the spinal cord. We then 
confirmed in a variety of acute nociceptive tests (von Frey, pin prick, cold, heat, and formalin) 
that the mice do not exhibit elevated pain sensitivities. We then continued with an in-depth 
analysis of GABAergic neurotransmission in hoxb82-/- and corresponding wild-type (2fl/fl) 
mice. Our electrophysiological recordings revealed a reduction in the amplitudes of light-
evoked GABA-IPSCs in hoxb82-/- mice with no change in decay kinetics. We found no 
changes in the amplitudes of currents evoked by superfusion with GABA and an increase 
rather than a decrease in the amplitudes of tonic GABAergic currents. One might hence 
argue that the absence of a pronociceptive phenotype in hoxb82-/- mice comes from 
preserved tonic GABAergic currents mediated by extrasynaptic GABAARs, while synaptic 
GABAARs would have no or only very little impact on spinal nociceptive control. Although this 
explanation cannot be fully ruled out at present, it seems unlikely to us as these tonic 
currents are very small and are present only in a subset of cells (Belelli et al., 2005). An 
alternative and in our opinion a more likely explanation for the absence of a pronociceptive 
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phenotype is the presence of some kind of compensatory mechanisms that would counteract 
diminished GABAergic inhibition at synapses by up-regulating another form of inhibition or by 
down-regulating excitation in nociceptive circuits. We found no evidence for an up-regulation 
of glycinergic inhibition, leaving us with the observed increase in the amplitude of tonic 
GABAergic currents as the only change in the GABAergic system that could potentially 
compensate for the loss of synaptic GABAergic inhibition.  
Tonic GABAergic currents originate from the activation of extrasynaptic GABAARs by ambient 
extracellular GABA. Since GABA concentrations are low outside synaptic clefts, GABAARs 
mediating tonic GABAergic currents must have a high affinity for GABA. Previous work has 
shown that 4- and 5-GABAARs fulfill these criteria (Delgado-Lezama et al., 2013; Fritschy 
and Panzanelli, 2014). Given the sparse expression of 4-GABAARs in the spinal cord of wild-
type mice (Paul et al., 2012), one could argue that increased tonic inhibition originated more 
likely from 5-GABAARs than 4-GABAARs (Perez-Sanchez et al., 2016). On the other hand, 
currents activated by exogenous GABA showed reduced sensitivity to HZ-166 in hoxb82-/- 
mice suggesting an up-regulation of non α1, α2, α3, α5 GABAARs. Future experiments should 
aim to verify whether 4-GABAARs were up-regulated upon spinal 2 ablation and hence 
contribute to the increased tonic inhibition in hoxb82-/- mice. To this end, THIP (4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridin-3-ol), a δ-preferring GABAAR agonist, may be useful to 
elucidate the role of 4-GABAARs, as they are known to associate with the δ subunit rather 
than the γ2 subunit (Storustovu and Ebert 2006; Bonin et al., 2011). 
In addition to compensatory mechanisms originating from within the GABA of glycinergic 
system, we had also addressed potential changes in the glutamatergic system and had 
quantified excitatory synaptic input from primary nociceptors to the spinal dorsal horn. There 
was a trend towards more reliable synaptic transmission from primary nociceptors to second 
order LII neurons in hoxb82-/- mice, consistent with diminished GABAergic inhibition of 
excitatory transmission.  
We also investigated the mRNA levels of the vesicular glutamate transporters VgluT1-3 in the 
DRGs of hoxb82-/- mice. In wild-type mice, VGluT1 is expressed mainly VgluTs are 
responsible for transporting the excitatory neurotransmitter glutamate into vesicles located 
within the terminal of primary afferent fibers (El Mestikawy et al., 2011). We found reduced 
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mRNA levels of VgluT2, but no changes VgluT1 and VgluT2. Although statistically significant, 
the change in VgluT2 mRNA expression was rather small and did not translate into altered 
VgluT2 protein expression in the dorsal horn, the site to which the VgluT protein expressed in 
DRG neurons is transported. It is therefore unlikely that the observed change in VgluT2 
mRNA levels is of biological relevance.  
As a final experiment, we had also investigated protein levels of serotonin (5-HT) and its 
producing enzyme TPH2 (tryptophan hydroxylase 2), by use of immunohistocytochemistry. 5-
HT is synthesized in neurons of the nucleus raphe magnus, located in the hindbrain, which is 
the main source of spinal 5-HT release (Hornung, 2003). Spinally released serotonin can 
mediate both hyperalgesia and antinociception, depending on which subtype 5-HT receptors 
is activated (Yaksh and Wilson, 1979; Furst, 1999; Diniz et al., 2015). Activation of spinal 5-
HT3 receptors is antinociceptive (Fukushima et al., 2009; Kim et al., 2015). We demonstrated 
increased protein levels of serotonin and TPH2 in both the superficial and deep dorsal horn 
of the spinal cord in hoxb82-/- mice. These results could suggest an increased serotonergic 
tone in the spinal cord of hoxb82-/- mice as the most likely mechanism of compensation. 
In the present study, we had also compared the effects of HZ-166 on GABAergic membrane 
currents in hoxb82-/- and 2fl/fl mice. Consistent with a major role of the 2 subunit in the 
superficial dorsal horn, we found reduced potentiation by HZ-166 in neurons of hoxb82-/- 
mice. The finding that potentiation was reduced but not completely lost is consistent with 
the presence of additional  subunits that can form benzodiazepine (HZ-166) sensitive 
GABAARs. Despite this remaining potentiation by HZ-166 the analgesic effect of HZ-166 was 
virtually lost in hoxb82-/- mice. A very similar phenotype has been found previously by Paul 
et al. (2014) in the zymosan A test, which is another inflammatory pain model. By contrast, 
analgesic effects in neuropathic mice were only partially reduced in hoxb82-/- mice. This 
difference may indicate that different dorsal horn neuronal circuits control inflammatory and 
neuropathic pain.  
In summary, this study confirmed the pivotal contribution of 2-GABAARs in the analgesic 
actions of GABAAR modulators. A surprising finding was that mice lacking this receptor 
subtype did not show a pronociceptive phenotype. Our data suggest that an up-regulation of 
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serotonergic input to the spinal dorsal horn compensated for loss of pain control by synaptic 
GABAARs in these mice. 
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I Abstract - Part A 
 
The superficial dorsal horn (sdh, LI/II) is an important relay station for incoming nociceptive 
signals from the peripheral nervous system. In this region, inputs are modulated by a 
network of inhibitory and excitatory interneurons before being further relayed by projection 
neurons to supraspinal sites in the brainstem and the thalamus. Many studies have 
investigated synaptic transmission between nociceptive fibers and LII neurons, and 
techniques such as paired recording revealed tight connectivity between excitatory and 
inhibitory neurons in LII but also connectivity across laminae. More recently, advanced 
techniques have been developed that are able to map the spatial organization of excitatory 
and/or inhibitory synaptic transmission onto a specific neuron type. Previous studies have 
combined glutamate uncaging with laser scanning photostimulation (LSPS) and revealed the 
excitatory input zones onto neurons in LII, which extended across different laminae 
depending on the morphology of the postsynaptic neuron dendritic tree. In this current 
project, I first characterized light-evoked activity in vGAT::ChR2;GAD67eGFP double transgenic 
mice. In these mice, the majority of inhibitory neuron somata can be easily identified by their 
green fluorescence. In transverse slices prepared from these mice, both superficial and deep 
dorsal horn GAD67eGFP neurons fired action potentials reliably upon short (4 ms) stimulation 
with blue light. Laser scanning photostimulation was then used to determine the sites of 
origin of inhibitory input onto excitatory neurons of LII. Inhibitory input could be elicited both 
from white and grey matter stimulation although inputs from the grey matter dominated (79 
%). Within the dorsal horn grey matter, input from the superficial dorsal horn was more 
abundant than input from the deep dorsal horn (46 versus 33%).  
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II Introduction 
 
The spinal superficial dorsal horn laminae I and II (sdh, LI/ II) constitute the major termination 
site for nociceptive Aδ and C primary afferent fibers (Light and Perl, 1977). The incoming 
sensory stimuli are processed and modulated by a network of excitatory and inhibitory 
interneurons and ultimately converge onto projection neurons in LI that eventually transmit 
the final output to supraspinal CNS areas (Scheibel and Scheibel, 1968; Todd, 2010; Zeilhofer 
et al., 2012b). Maintaining a balance between excitation and inhibition is crucial for normal 
nociceptive processing, and down-regulation of the GABAergic and glycinergic network is 
thought to promote the development of chronic pain symptoms, such as allodynia and 
hyperalgesia (Sivilotti and Woolf, 1994; Zeilhofer and Zeilhofer, 2008; Zeilhofer et al., 2012a). 
The organization of primary afferent inputs to dorsal horn neurons has been extensively 
studied (Light and Perl, 1977; Woodbury and Koerber, 2003). It has been described that LII 
neurons mostly receive direct monosynaptic input from Aδ and C-fibers, in contrast to LIII 
neurons, which mostly receive direct inputs from Aβ-fibers (Lu and Perl, 2003; Torsney and 
MacDermott, 2006). The paired recording method demonstrated direct connections 
between LII inhibitory islet cells and excitatory neurons but also direct connections between 
LII and LI neurons (Lu and Perl, 2003, 2005). However, this technique is restricted to 
examining connections between neurons that are not far apart from each other essentially 
because a reduced field of view is necessary for precise visibility of the cells when 
penetrating whole-cell with the recording pipette. On the other hand, laser stimulation has 
permitted the study of the intrinsic connectivity between LII neurons but also translaminar 
connectivity between LII and LIII/IV interneurons (Kato et al., 2013). This technique is 
therefore well suited for studying spatial connectivity patterns in the spinal cord. Examining 
spatial organization of local and translaminar circuitry became possible with laser scanning 
photostimulation (LSPS) (Callaway and Katz, 1993; Katz and Dalva, 1994). LSPS employs 
scanning a region of interest with light while recording physiological responses from a 
defined neuron or set of neurons. It has been originally combined with caged 
neurotransmitters and nowadays can be also used in genetically modified animals which 
express light-sensitive actuators in subsets of neurons (such as vGAT::ChR2 mice). In the 
latter variant, LSPS ultimately activates a specific cell type and enables to record light-evoked 
      
80 
synaptic responses. For several spatial mapping approaches in acute spinal cord slices, UV 
light was used in LSPS experiments to uncage glutamate (Kato et al., 2007; Kato et al., 2009; 
Kato et al., 2013; Kosugi et al., 2013). Upon UV light stimulation, glutamate is uncaged and 
evokes firing in neurons located in close proximity to the glutamate release site. Ultimately, 
evoked synaptic responses can be recorded in postsynaptic neurons. Kato et al. (2013) have 
described a differential wiring of excitatory and inhibitory inputs to LII islet cells and mapped 
the organization of inputs to LIII-LIV neurons with this technique. The LSPS is an attractive 
tool to study inhibitory connectivity onto LII excitatory neurons in the dorsal horn.  
We applied LSPS in combination with an “optogenetic” mouse line the vGAT::ChR2-YFP 
instead of glutamate uncaging. LSPS was applied to acute coronal spinal cord slices from BAC 
transgenic vGAT::ChR2 mice. In these mice, ChR2 expression is driven by the vGAT promoter, 
which leads to expression of ChR2 in all inhibitory neurons of the central nervous system 
(CNS). Upon photoactivation of dorsal horn inhibitory neurons, we were able to record light-
induced IPSCs in postsynaptic LII excitatory neurons and map the inhibitory input zones onto 
these cells. In addition, we present some preliminary data on inputs to LII excitatory neurons 
that originate from the neurons in the rostral ventromedial medulla (RVM). Morphological 
reconstructions of postsynaptic neurons gave us additional insights on potential translaminar 
connectivity between LII and LIII neurons. This study provides information on the location of 
zones from which inhibitory input to excitatory LII neurons can be evoked.  
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III Aim of this chapter - Part A 
 
So far, most studies of dorsal horn inhibitory circuits focused on LII inhibitory interneurons 
and on excitatory or inhibitory inputs to these cells and to cells in the deeper laminae (Kato 
et al., 2007; Kato et al., 2009; Kato et al., 2013; Kosugi et al., 2013). The precise origin of 
inhibitory inputs onto LII excitatory neurons in pain processing however remains poorly 
understood. 
One aim of this chapter was to establish a method enabling us to examine the spatial 
organization of inhibitory synaptic inputs onto LII excitatory neurons. I started characterizing 
light-induced activity of GAD67eGFP;vGAT::ChR2 (referred to as GAD67eGFP) and then mapped 
the distribution of local inhibitory synaptic transmission to lamina II (LII) excitatory spinal 
dorsal horn neurons by combining LSPS and whole-cell patch-clamp recordings. Finally, I 
reconstructed the dendritic tree of two excitatory postsynaptic neurons in order correlate 
sites of the origin of inhibitory input with the morphology of the recorded neuron.  
  
      
82 
IV Material and methods 
 
Animals 
Animal procedures were approved by the Cantonal Veterinary Office (License permissions 
86/2013 and 031/2016). Experiments were either done in BAC transgenic vGAT::ChR2-YFP 
mice (Zhao et al., 2011) or in vGAT::ChR2-YFP;GAD67eGFP double transgenic mice. Mice were 
three to four-week-old and of either sex. 
Drugs and chemicals 
All chemicals were purchased from Biotrend (Anawa, Switzerland). 
Spinal cord slice preparation and electrophysiological recordings 
Animals were decapitated and underwent laminectomy. Transverse 400 µm thick slices of the 
lumbar spinal cord slices were prepared in ice-cold solution with the following composition 
(Dugue et al., 2009) (in mM): 130 K-gluconate, 15 KCl, 0.05 EGTA, 20 HEPES and 25 glucose 
titrated to pH 7.4 with KOH and supplemented with 50 μM D-APV to prevent glutamate 
excitotoxicity. Slices were then kept 30 min for recovery in a solution containing (in mM) 225 
D-Mannitol, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 0.8 CaCl2 and 8 MgCl2 and 25 glucose (37°C, 
bubbled with 95% O2, 5% CO2). Finally, slices were transferred to an artificial cerebrospinal 
fluid (aCSF), also known as extracellular solution with the following composition (in mM): 120 
NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 5 HEPES, 1 MgCl2, 2 CaCl2 and 14.6 glucose. Slices 
were transferred to a recording chamber and continuously perfused with aCSF equilibrated 
with 95% O2, 5% CO2 at a flow rate of 1ml min-1. Neurons in the sdh (LI, LII <150 µm from the 
dorsal margin) were visually identified with an iXON Ultra camera (Andor Technology, Belfast, 
UK) using the infrared gradient contrast equipment of the microscope (Zeiss Examiner. A1, 
Göttingen, Germany). Electrical recordings of the inhibitory neurons were done in current 
clamp mode with 0 pA holding current, and in voltage clamp mode at -60 mV holding 
membrane potential. In laser scanning photostimulation experiments (LSPS), whole-cell 
voltage-clamp recordings were performed at room temperature at a holding potential of -60 
mV on presumed excitatory (ChR2-) neurons. Patch pipettes were prepared from borosilicate 
glass capillaries and had an open tip resistance of 3-5 GΩ. Patch pipettes were filled with an 
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internal solution containing (in mM): 140 KCl, 4 MgCl2 + 6 H20, 10 HEPES, 10 EGTA, 2 MgATP, 
0.5 NaGTP when recording inhibitory inward currents in voltage-clamp mode. Recording 
action potentials in the current-clamp mode as well as light-evoked photocurrents in voltage 
clamp mode required the following internal solution (mM): 130 K-D-gluconate, 20 KCl, 2 
MgCl2+H2O, 0.05 EGTA, 2MgATP, 10 Na Hepes. 
i. Characterization of light-evoked responses in GABAergic and presumed glycinergic neurons 
Transverse spinal cord slices from GAD67eGFP mice were used for the experiments. The 
identification of GAD67eGFP cells was done through excitation of the tissue with the 490 nm 
excitation fluorescence wavelength (GFP reporter). Fluorescence was easy to detect in 
superficial dorsal horn GAD67eGFP neurons due to their strong expression of GFP in the soma. 
Deep dorsal horn inhibitory neurons which release both GABA and glycine (Todd, 1990) also 
express GAD67eGFP but at intensities too low to be reliably detected above the neuropil 
fluorescence background of the ChR2-YFP. Their inhibitory phenotype was identified by the 
presence of the photocurrent. Access resistance of the cell was continuously monitored by 
giving short hyperpolarizing steps (-5 mV) between the different light stimulations. 
Recordings were discarded if the access resistance changed > 20% between the beginning 
and the end of the experiment. Three consecutive light stimulations of 4 ms (473 nm) 
starting at 20.4 mW/mm2 and decreasing step-wise to a final power density of 11.5 
mW/mm2, were applied to the cell soma. Light-evoked action potentials from either 
GAD67eGFP or presumed glycinergic cells in LII and III, respectively, were recorded. The firing 
success rate (i.e. sensitivity of the cells to different light intensities) was measured in each 
population of inhibitory neurons. Three action potentials out of three consecutive light 
stimulations (of equal intensity) were considered as 100% success rate. In voltage clamp 
experiments, light-evoked photocurrents from either GAD67eGFP or presumed glycinergic cells 
were recorded at 1 s and 4 ms light exposures with similar decreasing intensities as in current 
clamp experiments (i.e., 20.4 -11.5 mW/mm2).  
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ii. Laser scanning photostimulation (LSPS) 
The laser and optical fiber were obtained from RappOptogenetics (Hamburg, Germany). The 
laser beam was coupled to a single optic fiber directly coupled into an Axio Examiner.A1 
fixed-staged microscope (Zeiss, Göttingen, Germany). Scanning was done by the UGA-40 
GEO, which harbors a set of rotating mirrors allowing the laser beam to move in a pre-
configured direction. The settings for the laser beam scanning directions were done by using 
the UGA-40 software (RappOptoelectronics, Hamburg, Germany). Ultimately, these 
parameters enabled to direct the laser beam to follow a 20 x 20 stimulation grid from left to 
right, and top to bottom. The dimensions of the stimulation grid for mapping the inhibitory 
synaptic responses were set to 800 µm x 800 µm (400 stimulation sites à 40 x 40 µm). Each 
area was illuminated for 4 ms and an interval of 96 ms with no light stimulation was 
implemented between stimulation of neighboring areas. Stimulation was done through a 10x 
water immersion objective. The shape and size of the stimulus were chosen to maximize 
sensitivity in the detection of synaptic inputs and hence avoid excluding regions of the dorsal 
horn that could have potential synapses with the recorded neuron. The light intensity 
reaching the tissue was 2.3 mW/mm2. In most cases, five consecutive scans were applied on 
the tissue.  
Transverse spinal slices from vGAT::ChR2 mice were used to record inhibitory input from 
excitatory interneurons of LI-LII. LII was recognized under the 10x water-immersion objective 
by its transparent appearance. Individual neurons were visualized with a 40x immersion 
objective. Excitatory neurons were identified by the absence of light-evoked photocurrent 
after a 1s light pulse directed onto their soma. Recording of synaptic responses to 
photostimulation was done in whole-cell mode. Light-evoked inhibitory currents were 
recorded at a holding potential of -60 mV. A high chloride-based internal solution (KCl, see 
Spinal cord slice preparation and electrophysiological recordings) lead to a chloride reversal 
potential close to zero and hence large inhibitory inward currents could be obtained. Access 
resistance of the cell was continuously monitored by giving short hyperpolarizing steps (-5 
mV) between each laser photostimulation. Recordings were discarded if the access resistance 
changed > 20%. All electrical signals were sampled at 5 kHz and filtered at 2.9 kHz. Data was 
analyzed using IgorPro (WaveMetrics, Inc.,USA).  
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Data analysis 
A macro (see Appendix 1: Macro) was built to analyze each trial (stimulation point) from 
individual scans in control and drug conditions (i.e. 1 scan, 400 trials). The threshold set for 
detecting light-evoked IPSC events was baseline ≥ 2*standard deviation of the noise obtained 
during an interval where no synaptic event was visible. The outcome of one scan delivered a 
20 x 20 probability table, and a 20 x 20 heat map. The probability table provided values 
corresponding to the number of times an inhibitory input was detected by the macro after a 
total amount of scans. The threshold we considered for inhibitory inputs to be triggered was 
>1 event per trial. For each recorded cell, an infra-red (IR) image of the spinal dorsal horn was 
taken with the 10x objective and overlaid onto the 20 x 20 heat map. Therefore, 1) the 20 x 
20 probability table could be divided into two halves: superficial and deep dorsal horn, 2) 
Each value of the table was assigned an identity: grey matter LI/LII (GM LI/LII), grey matter 
LIII-LV (GM LIII-LV), dorsal white matter (WM dorsal), lateral/medial white matter (WM 
lat/med). The sum of events was calculated for each recorded cell in control conditions in 
each of these four categories. In some cases, more than five scans were performed on the 
spinal dorsal horn.  
Dendritic tree morphology 
Recording pipettes were filled with an internal solution containing 0.5% biocytin (Sigma 
Aldrich) in order to visualize the dendritic tree of LII excitatory neurons. After the recordings, 
the pipette was carefully retracted from the recorded neuron. Slices were fixed in 4% PFA 
containing 15 % picric acid and subsequently stored in 10 % saccharose-0.05% NaN3 in 
phosphate buffer saline (PBS) until further analysis. Slices were washed briefly in PBS and 
permeabilized extensively in 1% TritonX-100-10% normal NGS in PBS for up to 5 hours at 
room temperature. Subsequently, slices were incubated at 4°C for two days in Alexa Fluor 
488-conjugated streptavidin (1:150; Dianova) to label the biocytin-filled neuron. All 
antibodies were diluted in 10% NGS-0.1% Triton X-100 in PBS. Sections were air-dried and 
mounted on gelatin coated glass slides (Thermos Scientific) in fluorescence mounting 
medium (Dako, Agilent Technologies). Fluorescent images were acquired on a Zeiss LSM710 
Pascal confocal microscope using a 0.8 NA x 20 Plan apochromat objective and the ZEN 2012 
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software (CarlZeiss). A 20 plane Z-stacks (step size: 2.4 µm) was generated to obtain a 3D 
view of the dendritic tree extension.  
Reconstruction of the dendritic tree was done with the Simple Neurite Tracer plug-in from Fiji 
(Image J). The reconstruction resulted in a z-stack that was then converted into a maximal 
intensity projection 2D image that was then overlaid to the corresponding heat map. This 
allowed the visualization of synaptic events onto the postsynaptic neuron. 
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V Results 
 
Inhibitory neurons of both the superficial and the deep dorsal horn respond reliably at strong 
light intensities 
In the first experiments, we performed targeted recordings in slices from 
GAD67eGFP;vGAT::ChR2-YFP (henceforth referred to as GAD67eGFP) mice. GABAergic neurons of 
the superficial dorsal horn were reliably identified under the 40x objective due to the intense 
eGFP expression in their somata driven by the GAD67 promoter (Figure 1A). These inhibitory 
neurons of the deep dorsal horn also express GAD67eGFP but their fluorescence was too weak 
to be detectable above the background of the neuropil ChR2-YFP fluoresence. Their 
inhibitory phenotype was identified by the presence of the photocurrent in cells of the deep 
dorsal horn (Figure 1B). We recorded light-evoked photocurrents in voltage-clamp mode 
after 1 s and 4 ms light pulses in both of these inhibitory cell subpopulations. Peak-to-
baseline photocurrent amplitudes in the example traces shown in Figure 1C displayed no 
significant differences in amplitude between both cell types after 1 s (superficial dorsal horn 
inhibitory neuron: -114 pA; deep dorsal horn inhibitory neuron: -132 pA) and 4 ms 
(superficial dorsal horn inhibitory neuron: 123 pA; deep dorsal horn inhibitory neuron: 103 
pA) light stimulations.  
We then characterized the firing activity of both superficial and deep dorsal horn inhibitory 
neurons at different light intensities (20.4 - 11.5 mW/mm2, Figure 1E). At the maximum 
intensity both superficial and deep dorsal horn inhibitory neurons fired action potentials 
upon 4 ms light pulse exposure (473 nm, 20.4 mW/mm2, Figure 1D). Both superficial and 
deep dorsal horn inhibitory neurons also responded to light intensities ranging from 12.70 - 
20.40 mW/mm2 with reliable action potential firing. At lower light intensities, both inhibitory 
cell types were not able to sustain high fidelity firing in response to blue light (Figure 1E).  
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Figure 1. Characterization of light-evoked responses in inhibitory neurons. A, Fluorescence image of a 
GAD67eGFP cell identified by the GFP reporter in the superficial dorsal horn lamina II (sdh, LII) under a 40x 
objective (left). The same cell pictured in IR (right). The recording pipette is visible in both pictures and allowed 
us to record whole-cell activity from sdh inhibitory cells. B, IR image taken under the 10x objective that enabled 
us to target presumed glycinergic interneurons in the deep dorsal horn (ddh, LIII). The recording pipette is 
shown in grey. C, Example traces of voltage-clamp recordings in sdh and ddh inhibitory cells showing light-
evoked photocurrents after 1s (blue bar, 473 nm, 716 mW/mm2) and 4 ms light exposures (473 nm, 20.4 
mW/mm2), respectively. D, Current clamp recordings representing light-evoked action potentials in a sdh and 
ddh inhibitory cell after a 4 ms light pulse (λ=473 nm, power density: 20.4 mW/mm2). E. Firing success rate 
measured in sdh and ddh inhibitory cells after 4 ms light pulse stimulation. Light-intensity was decreased step 
wise from 20.4 - 11.5 mW/mm2 (473 nm). For each light intensity step we triggered three light-stimulations. 
Inhibitory inputs onto LII excitatory neurons originate from the grey and white matter 
After characterizing the reliability of firing action potentials to given light stimulation 
intensities, we mapped the distribution of spinal inhibitory inputs onto LII excitatory neurons. 
To this end, we applied LSPS to acute slices of single transgenic vGAT::ChR2 mice (Figure 
2A,B). While the blue light was stimulating the defined areas of the dorsal horn (squared 
shape, Figure 2B), we recorded light-evoked IPSCs from the postsynaptic neuron (Figure 2C). 
Light-evoked IPSCs could be reliably triggered by the light stimulus (inset, Figure 2C). Using 
this approach, we recorded light-evoked IPSCs from a total of 21 cells. From the probability 
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heat maps, we observed that all recorded neurons received inhibitory inputs from LI and LII, 
and 85% received inhibitory inputs also from the deep dorsal horn (LIII). 
 
Figure 2. Laser scanning photostimulation setup. A, Acute transverse spinal cord slice taken from a 
vGAT::ChR2-YFP mouse under the 4x objective. ChR2-YFP is driven by the vGAT promoter and hence expressed 
in all inhibitory neurons. Expression of ChR2 is rendered visible by a YFP fusion protein coupled to the channel. 
Laminae I to IV are represented on the right dorsal horn (black dotted lines). B, IR image of the spinal dorsal 
horn taken with the 10x objective and a representative 20 x 20 stimulation grid overlaid to it (blue crosses). The 
light pulse (blue square, 40 x 40 µm) followed the grid and scanned the dorsal horn from left to right, top to 
bottom. C, Voltage-clamp recording trace after one scan of light-stimulation (blue dotted line, 400 light 
stimulations, 473 nm, 2.3 mW/mm2).  Inset shows five reliable light-evoked IPSCs upon 4 ms light exposure. D, 
20 x 20 probability heat map obtained after five consecutive scans of the dorsal horn. Each trial constituting the 
heat map has identical coordinates to the stimulation points in B. These maps show the distribution of inhibitory 
input zones (represented as hot spots) in the dorsal horn. Hot spots that yield a light-evoked signal with a high 
probability are shown in yellow (colour scale, 1). Hot spots become darker with lower probability of 
neurotransmission (0, black). 
We next investigated whether different populations of inhibitory neurons had a differential 
contribution to the total inhibitory neurotransmission in LII excitatory neurons. We 
performed LSPS in control (ctrl) and bicuculline (bic, 20 µM) conditions. Figure 3A (left 
column) shows two examples from two different cells. Top row shows an excitatory cell in LII 
(symbolized by a coloured spot) where most inputs originated from the lateral and dorsal 
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white and superficial dorsal grey matter (ctrl, Figure 3A, top). Laminar layers are represented 
by dotted white lines (LI-LIV). After application of bicuculline the probability of inhibitory 
transmission was reduced (Bic, Figure 3A, top). The bottom row, shows in control, clusters of 
inhibitory input in the lateral and dorsal white matter as well as in the superficial and deep 
dorsal horn grey matter. After bath-application of bicuculline, the probability of synaptic 
transmission was also reduced (Figure 3A, bottom). 
In the probability heat maps, events appearing only once in a total of five scans (i.e., with a 
probability of 0.2) were considered as spontaneous rather than light-evoked signals. Such 
assumption was based on the fact that the probability of obtaining twice the same 
spontaneous event in all five scans was less than 5%. In 17 out of 21 cells, we assessed that 
the events were light-evoked and not spontaneous with more than 95% certainty. 
Furthermore, we filled the postsynaptic neuron with biocytin to reconstruct the dendritic 
tree, and to compare its position with the inhibitory input zones of the postsynaptic neuron. 
We were able to reconstruct two cells (Figure 3B) in which the dorsoventrally dendritic fields 
extended to the deep dorsal horn (LV and LIII, respectively). These cells showed 
characteristics of vertical cells and were therefore classified as such. In both cells we 
observed inhibitory inputs on parts of the reconstructed cell but also in the deep dorsal horn 
and the dorsal white matter (Figure 3B). We indicated in a virtual right dorsal horn slice the 
somas of 19 excitatory cells that we were able to identify after the recordings. All somas were 
located in LII of the dorsal horn (Figure 3C).  
To characterize the spatial distribution of inhibitory inputs we divided the probability heat 
maps from a total of 19 neurons into four regions: 1) dorsal white matter, 2) lateral/medial 
white matter, 3) grey matter (LI-LII, superficial dorsal horn), and grey matter (LIII-LV, deep 
dorsal horn). The results showed that 79% of the inputs arrived from stimulation of the grey 
matter and 21% from the white matter. The majority of inhibitory inputs occured in the 
superficial dorsal horn grey matter (46%, GM LI-LII) followed by the deep dorsal horn grey 
matter (33%, GM, LIII-LIV). The dorsal white matter contributed to 18% of the inputs in 
contrast to the lateral/medial white matter, which only contributed to 3% of the overall 
inhibitory neurotransmission.  
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Figure 3. Localization of inhibitory inputs onto excitatory LII neurons. A, IR images of two different excitatory 
neurons in LII from which we recorded light-evoked synaptic events (left column). Laminae borders are 
represented in white dotted lines. Probability heat maps obtained after five consecutive scanning 
photostimulations in control (ctrl, middle column) and after bath-application of bicuculline (bic, 20 µM, right 
column) conditions. The synaptic input zones are represented by “hot spots” following a color scale (i.e., yellow 
strong probability of input, dark red low probability of input). Dots were added to the heat maps to symbolize 
the soma of the post-synaptic neurons from which the signals were recorded. B, Left, IR images of neurons from 
LII that were filled for dendritic tree reconstruction. Right, 2D dendritic tree reconstruction of two neurons 
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overlaid onto the probability heat maps obtained after LSPS. Somas were added and symbolized by a spot. C, 
Soma location of all neurons for which mapping of synaptic input zones was done in coronal slices (n = 19 cells), 
plotted on a drawing of the right dorsal horn. The borders of laminae I-V are shown in white (dotted lines). D, 
Prevalence of white matter (WM) and grey matter (GM) inhibitory inputs onto excitatory LII neurons (white 
matter dorsal horn, WM dorsal:18±3.43%; WM lat/med dorsal horn: 3±0.90%,; GM superficial dorsal horn, 
LI/LII:46±3.31% ; GM deep dorsal horn, LIII/LV: 33±3.64%). Values represent average±SEM. 
The presence of descending inhibitory onto excitatory dorsal horn was verified in preliminary 
experiments where an AAV ChR2::mCherry virus was injected into the RVM of VgluT2::eGFP 
transgenic mice (Figure 4A). Targeted whole-cell recordings were performed on VgluT2::eGFP 
excitatory neurons of the sdh in coronal spinal cord slices. To characterize the 
neurotransmitter phenotype originating from the RVM, we used whole-field light stimulation 
(λ=473 nm, light exposure: 4 ms, field of view: 200-300 µm) on the sdh and recorded light-
evoked postsynaptic currents. Our results showed a reduction in the postsynaptic current 
amplitude after application of bicuculline (Total IPSC: -446 pA; glycinergic IPSC: -446.5 pA, 
Figure 4B). Light-evoked signals disappeared after subsequently adding strychnine. The 
present results confirm the presence of both GABAergic and glycinergic inputs from the RVM 
onto excitatory LII neurons. However, it is not possible to distinguish whether GABA and 
glycine are co-released from the same axon terminals or whether they are released by 
GABAergic and glycinergic neurons, respectively. 
 
      
93 
Figure 4. Mixed GABAergic/glycinergic inputs from the RVM modulate LII excitatory dorsal horn neurons.  A, 
Coronal section taken with the confocal microscope from a VgluT2::eGFP transgenic mouse brain after injection 
of an AAV-encoding ChR2::mCherry virus into the RVM (red, site of injection). B, Light-evoked postsynaptic 
currents after 4 ms light stimulation (blue bar 473 nm, 2.7 mW, field of illumination 200-300 µm) in control 
(black), bicuculline (Bic 20 µM, red) and bicuculline and strychnine (Stry 0.5 µM, green) conditions. 
Amplitude and latency properties of light-evoked IPSCs near the postsynaptic cell 
We studied the amplitude and latency values of light-evoked IPSCs in the region surrounding 
the soma of the postsynaptic cell. Our analysis focused on nine trials of light-evoked IPSCs 
(Figure 5A, a-i). From a total of 20 cells, the average baseline-to-peak amplitude value of the 
light-evoked IPSCs from the nine trials was 221±18.17 pA (average±SEM). The individual 
average amplitude values from each trial are summarized in the 3 x 3 table (Figure 5C, left).  
In summary, the amplitude values of the IPSCs ranged beteween 110 and 291 pA. The 
amplitude values from IPSCs recorded dorsally relative to the soma were statistically not 
different to those recorded ventrally relative to soma (dorsal: 180±13.56 pA; ventral: 
261±31.94 pA, p=0.20, Mann Whitney test). However, the amplitude values that were 
recorded from IPSCs medially located relative to soma were significantly larger than the 
amplitude values of IPSCs laterally located relative to soma (medial: 234±20.0 pA; lateral: 
195±32.80 pA, ***p<0.0001, Mann Whitney test). Regarding latency values, latencies from 
IPSCs recorded dorsal to the soma were significantly longer compared to latency values that 
were recorded from IPSCs ventral relative to soma (dorsal: 10.30±0.49 ms; ventral: 8.33±0.37 
ms, ***p<0.05 Mann Whitney test). However, we found no statistical difference between 
IPSCs latencies that originated either medially or laterally to the soma (medial: 9.28±0.45 ms; 
lateral: 10.75±0.70 ms, p=0.3, Mann Whitney test).  
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Figure 5. Amplitude and latency of light-evoked IPSCs surrounding the soma of the excitatory neuron. A, 
Example of superimposed light-evoked IPSCs from five stimulations (blue bar, 473 nm, 4ms, 2.3 mW/ mm2) 
recorded from an excitatory cell located at the center of the white boxed region (3 x 3) in B. B, The white box 
was placed around the eight trials surrounding the soma (e) of the recorded neuron. C, Amplitude and latency 
averages of five light-stimulations per trial surrounding the soma (middle box) recorded from a total of n=20 
cells. Amplitude of the events was measured from baseline to peak. a: 192±24 pA; b: 206±22.44 pA; c: 
110.50±12.81 pA; d: 235±26.60 pA; e:258±24.26 pA; f: 190.60±26 pA; g: 291.16±56.51 pA; h: 234±33.58 pA; i: 
274±88.5 pA. Values represent average±SEM. The latency was obtained by measuring the time between the 
onset of the stimulus and the inward current, respectively (refer to Figure 5A.h, inset orange dotted bar).  a: 
9.83±0.91 ms; b: 8.93±0.51 ms; c: 8.90±1.2 ms; d: 8.90±0.46; e: 7.73±0.43; f: 10.81±1.44; g: 8.98±0.84 ms; h: 
7.49±0.42 ms; i: 9.06±4.62 ms. Values represent average±SEM. Amplitude and latency ranges are translated 
into a color code going from red (highest values) to blue/white (lower values). 
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VI Discussion 
 
The purpose of the present study was to establish a protocol for LSPS in the spinal dorsal 
horn in order to locate the sources of synaptic inhibitory input onto excitatory LII neurons. 
We worked with acute spinal cord slices from BAC transgenic vGAT::ChR2 mice and thus 
relied on the activation of inhibitory GABAergic and glycinergic neurons to measure light-
evoked IPSCs in excitatory neurons. We found it necessary to investigate possible 
discrepancies in firing activity or depolarization current amplitudes of the two neuronal 
subpopulations in response to the light paradigms that were used for the LSPS experiments 
(473 nm, light duration: 4 ms, power density: 20.4 mW/mm2), and to assess whether the 
light-evoked responses preferentially originated from GABAergic or glycinergic neurons. We 
used GAD67eGFP mice for the characterization of GABAergic neurons. GAD67eGFP cells have a 
strong expression of GFP in the cell body, which made it easy to visualize under the 
epifluorescence microscope (Tamamaki et al., 2003). Presumed glycinergic neurons were 
recorded from the deep laminae. We found that inhibitory neurons of both the superficial 
and deep dorsal horn reliably fired action potentials upon the light stimulation (λ=473 nm, 
light exposure: 4 ms, power density: 20.4 mW/mm2).  
In our LSPS experiments, we successfully activated presynaptic inhibitory neurons and 
thereby mapped the inhibitory input zones onto excitatory LII neurons. Using this approach, 
we showed that excitatory LII neurons received almost 80% of inhibitory inputs from the grey 
matter and only 21% from the white matter. The latter inputs may arise from the stimulation 
of fibers descending to the dorsal horn from supraspinal areas, such as the brainstem 
(Vanegas and Schaible, 2004). It is indeed known that superficial dorsal horn neurons receive 
GABAergic and glycinergic inputs from neurons located in the RVM (Basbaum and Fields, 
1984; Kato et al., 2006; Lau and Vaughan, 2014).  
We suggest that in the LSPS experiments, terminals of descending fibers originating from 
inhibitory cells in the brainstem are depolarized due to the presence of vGAT::ChR2 that is 
expressed by all inhibitory neurons of the CNS (Zhao et al., 2011). Two cases could explain 
how excitatory neurons from the sdh receive inhibitory inputs from the white matter. In the 
first case, axon terminals of inhibitory neurons from the RVM cross the white-grey matter 
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border and target excitatory neurons in the spinal dorsal horn. In the second case, dorsal 
horn excitatory neurons have dendrites extending to the white matter onto which 
descending inhibitory axon terminals synapse. Radial cells could potentially be good 
candidates for crossing the grey-white matter border given the orientation of their dendritic 
tree, which also expands dorsally (Yasaka et al., 2007). Morphological reconstruction of the 
postsynaptic neuron could allow us to discriminate these two situations. 
The original purpose of reconstructing the dendritic tree of the recorded cells with biocytin 
was to correlate the inhibitory input zones with the postsynaptic dendritic tree. Our two 
dendritic reconstructions showed that dendritic trees of LII excitatory neurons extended into 
LIII deeper laminae. Work from Kato et al., (2013) has reported excitatory synaptic inputs 
from sdh neurons onto LIII-LIV neurons. It is tempting to speculate that LIII/LIV dorsal horn 
neurons also receive inputs from sdh inhibitory neurons. Our preliminary results would 
therefore support the idea of translaminar communication, important in nociceptive 
processing, which would take place between ventrally extending dendritic trees from LII 
neurons and neurons in lamina III. The reconstruction that was obtained from the excitatory 
neurons strongly resembled the structure of vertical cells that were reported to account for 
one-third of all excitatory neurons in LII (Yasaka et al., 2010), and being non-GABAergic (Todd 
and McKenzie, 1989). The reconstructed dendritic trees predominantly extended in the 
ventral direction, which agrees with previous research that showed the same features among 
lamina II excitatory interneurons (Grudt and Perl, 2002; Punnakkal et al., 2014). We are 
aware, however, that having coronal spinal sections might severe dendritic structures 
extending in the rostro-caudal axis and hence reduce the number of cells identified as either 
radial or central cells, other morphological classes of excitatory dorsal horn neurons (Grudt 
and Perl, 2002; Maxwell et al., 2007; Yasaka et al., 2010).  
We were interested in knowing the amplitude values surrounding the soma of the excitatory 
postsynaptic neurons, since the cell body was the only structure that we could locate with 
confidence on the probability heat maps. Our results showed high amplitude values (100-300 
pA) for IPSCs evoked close to the soma. We are aware that amplitude values depend on 
several factors, such as the type of stimulation (electrical, light stimulation), the amount of 
synapses stimulated upon light exposure, and also the amount of postsynaptic receptors. 
One could speculate that the amplitude values measured from inhibitory inputs around the 
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soma might be larger than those originating from structures located distally to the cell body 
such as dendrites, due to a lower influence of dendritic filtering. Recording directly from 
dendrites could be an alternative to reduce the influence of dendritic filtering of the signal. 
This amplitude analysis should in addition be complemented with an improved 
reconstruction of the postysynaptic neuron in order to locate with precision the inhibitory 
inputs onto the structures of the postsynaptic cell.  
In addition to amplitude, we also investigated the latency values from light-evoked IPSCs. Our 
analysis revealed latency values between 7-10 ms. We believe that the latency values we 
measured were slightly higher due to an additional 4 ms latency occuring between the TTL 
(transistor-transistor logic) trigger and the light transmission onset in our system, probably 
due to mechanical and electronical components of the light source used. Our latency values 
most likely reflect inhibitory monosynaptic connections, which are known to have short 
latencies (Rousseau et al., 2008; Jin et al., 2016). 
In the present study, LSPS experiments in the spinal dorsal horn allowed us to visualize 
inhibitory input zones onto excitatory LII interneurons. We showed that most of the 
inhibitory inputs originated from the grey matter. However, a smaller percentage also arrived 
from the white matter. In the future, it would be desirable to complement LSPS experiments 
with complete reconstruction of the postsynaptic neurons. This would include 
reconstructions of the axon to learn which laminae are targeted by the recorded cell. In 
addition, the neuronal reconstruction would likely reveal sites on the postsynaptic neuron 
that preferentially receive inhibitory inputs. Furthermore, one should consider using 
parasagittal instead of coronal spinal cord slices, as this would be more likely to preserve the 
morphology of the recorded excitatory cells and the presynaptic inhibitory cells, both of 
which are mostly oriented in the rostro-caudal axis (Kato et al., 2007; Punnakkal et al., 2014).  
Mapping the origin of inhibitory input onto excitatory neurons of LII together with the 
preliminary experiments focusing on descending inputs from the RVM, provide new insights 
into the origin intrinsic and supraspinal circuits, which are important in nociceptive pain 
processing. Furthermore, this set of data confirms that the excitability of excitatory neurons 
in LII is accurately controlled by a strong network of inhibitory input. 
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Appendix 1: Macro 
--------------------------------------------------------------------------------------------------------------- 
#pragma rtGlobals=1 // Use modern global access method. 
Macro FindEvents(filename,First4digits,secondNumber,NTraces) 
String PMWavename, IgorWaveName, AmpspaceFileName,SpaceFileName, SpacePictureFileName, 
FileName,AmpSpacePictureFileName,First4digits,secondNumber,AmpSpaceFileName2,AmpSpacePict
ureFileName2 
Variable avg,SD,threshold,j,NumPoints, stop, k,yi, xi, NumofE,baseline,peak,n, lowlim, uplim, flag, 
jlimit,field,NTraces, statlim 
NewPath ExpData "Macintosh HD:Users:UserName:Desktop:Optogenetics:ScanData"   
silent 1              
Make /N=(20,20)/O space,ampspace,ampspaceN    
Make /N=20 ye,xe 
xe=NAN 
ye=NAN 
space=0 
ampspace=0 
n=1   
AmpSpaceFileName=Filename+"ampspace" 
AmpSpaceFileName2=Filename+"ampspaceN" 
AmpSpacePictureFileName=FileName+"AmpspacePicture" 
AmpSpacePictureFileName2=FileName+"AmpspacePictureN" 
SpaceFileName=Filename+"space" 
SpacePictureFileName=FileName+"Picture" 
 Display /W=(5,44,215,235);AppendImage ampspace  
  ModifyImage ampspace ctab= {-10e-11,0,YellowHot,1}  
  ModifyGraph width=141.732,height=141.732 
  SetAxis left 20,-1  
  Setaxis bottom -1,20  
  Display /W=(220,44,430,235);AppendImage ampspace  
  ModifyImage ampspace ctab= {*,0,YellowHot,1}  
  ModifyGraph width=141.732,height=141.732 
  SetAxis left 20,-1 
  Setaxis bottom -1,20 
 Display /W=(435,44,645,235);AppendImage space  
  ModifyImage space ctab= {0,2,YellowHot,0} 
  ModifyGraph width=141.732,height=141.732 
  SetAxis left 20,-1 
  SetAxis bottom -1,20 
Do 
 Make /N=1200/O amp  
 amp=NAN  
 PMWavename=FileName+"_1_"+secondNumber+"_"+num2str(n+3-1)+"_1.ibw" 
  IgorWaveName=First4digits+"_1_"+secondNumber+"_"+num2str(n+3-1)+"_1"  
  print PMwavename 
  LoadWave  /P=ExpData PMWavename 
  Wavestats /Q $IgorWaveName  
  $IgorWaveName-=V_avg  
  Duplicate /O  $Igorwavename Trace 
  Duplicate /O Trace DiffTrace  
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  Duplicate /O Trace IntTrace 
  Differentiate Trace /D=DiffTrace  
  WaveStats /Q DiffTrace  
 Threshold=-2*V_sdev 
 j=0.210 
 k=0 
 field=1 
 stop=400 
 do 
 jlimit=0.2+(field*0.10118) 
 flag=0 
  do 
   if (DiffTrace(j)<threshold) 
   if (DiffTrace(j+0.0002)<threshold) 
   if  (DiffTrace(j+2*0.0002)<threshold) 
    ye(field-1)=trunc((field-1)/20) 
    xe(field-1)=(field-1) -(ye(field-1)*20) 
    yi=ye(field-1) 
    xi=xe(field-1) 
    space[xi](yi)+=1 
    lowlim=0.2+((field)*0.10118) 
    uplim=lowlim+0.10118 
    statlim=lowlim+0.002 
 Wavestats /Q/R=(lowlim,statlim) trace 
 trace-=V_avg 
 integrate trace /D=inttrace 
 ampspace[xi](yi)+=(inttrace(uplim)-inttrace(lowlim))/5 
 j=((trunc((j-0.2)/0.10118))+1)*0.10118+0.2 
 field+=1 
 flag=1 
endif 
endif 
endif  
j+=0.0002 
while(j<=jlimit) 
 if (flag==0) 
 field+=1 
endif 
while(field<=400) 
killwaves $IgorWaveName 
n+=1 
while (n<=NTraces) 
Save/G/W/P=ExpData space as SpaceFileName 
SavePICT/C=0/P=ExpData as SpacePictureFileName 
Save/G/W/P=ExpData ampspace as AmpSpaceFileName 
ModifyImage ampspace ctab= {-10e-11,0,YellowHot,1} 
SavePICT/C=0/P=ExpData as AmpSpacePictureFileName 
ModifyImage ampspace ctab= {*,0,YellowHot,1} 
SavePICT/C=0/P=ExpData as AmpSpacePictureFileName2 
EndMacro 
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Part B 
Characterization of inhibitory neurotransmission onto 
excitatory dorsal horn interneurons after glycinergic 
neurons ablation in the spinal cord  
 
Part B contains my contributions to a published study (Foster et al., 2015).  
Some parts have been paraphrased from the original work. 
 
Targeted ablation, silencing, and activation establish glycinergic dorsal horn neurons as key 
components of a spinal gate for pain and itch. Neuron, 2015 
Foster E, Wildner H, Tudeau L, Haueter S, Ralvenius WT, Jegen M, Johannssen H, Hösli L, 
Haenraets K, Ghanem A, Conzelmann KK, Bösl M, Zeilhofer HU 
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I Abstract - Part B 
 
The gate control theory of pain (Melzack and Wall, 1965) postulates that inhibitory 
interneurons in the superficial substantia gelatinosa act as “gate keepers”, either facilitating 
or stopping further transmission of nociceptive inputs to higher levels of the brain. 
Experimental evidence has demonstrated that dysfunction of inhibitory interneurons of the 
dorsal horn contributes to induction and maintenance of chronic pain states. In this project, 
we investigated the role of glycinergic interneurons in spinal nociceptive processing by 
ablating or silencing these neurons through intraspinal injection of adenoassociated virus 
vectors (AAV) harboring constructs for cre dependent expression of diphtheria toxin subunit 
A (DTA). My contribution was to quantify (i) the contribution of glycine to the inhibitory input 
onto excitatory LII neurons and (ii) the loss of glycinergic input upon local segmental ablation 
of glycinergic neurons. To enable reliable comparisons between slices taken from different 
animals, inhibitory neurotransmission was evoked employing optogenetics as this technique 
allows stimulation conditions to remain stable over time. We found that 70% of the gross 
inhibitory input onto LII excitatory neurons are mediated by glycine receptors. Further 
analyses reveal that most of the inhibitory input originates from mixed GABAergic/glycinergic 
neurons, which located in the deep dorsal horn. These results provide evidence for a major 
contribution of glycinergic neurons to inhibition of dorsal horn excitatory neurons. 
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II Introduction 
 
The pivotal role of inhibitory synaptic transmission in spinal control of nociceptive signals was 
already proposed in the gate control theory of pain by Melzack and Wall (Melzack and Wall, 
1965). In the original model, signals arriving from non-nociceptive (low-threshold myelinated 
sensory fibers) and nociceptive fibers (high-threshold unmyelinated sensory fibers) interact 
with local inhibitory interneurons to “open” or “close” the pain gate. This theory attributes a 
crucial role to inhibitory neurons in controlling the activity of spinal dorsal horn output 
neurons. Plenty of evidence suggests that the spinal dorsal horn serves as an important relay 
platform for synaptic processing in the pain pathway (Todd, 2010; Zeilhofer et al., 2012b). 
Maladaptive changes at this site, such as reduced inhibitory control over dorsal horn 
neuronal circuits lead to increased excitability and spontaneous activity of dorsal horn 
neurons, and hence contribute to a wide variety of pain pathologies manifested as allodynia 
(painful sensation to innocuous stimuli), and hyperalgesia (enhanced sensitivity to noxious 
stimuli) (Sorkin et al., 1998; Woolf and Salter, 2000; Drew et al., 2004; Sandkuhler, 2009; 
Kuner, 2010).  
In the dorsal horn, inhibitory neurons represent about one-third of the total neuronal 
population. They use γ-aminobutyric acid (GABA) and glycine as fast inhibitory 
neurotransmitters (Zeilhofer et al., 2012b). Glycinergic neurons are mainly located in the 
deep dorsal horn (LIII-LV), the termination area of non-nociceptive afferent fibers (Todd and 
Spike, 1993). In addition to glycine, these neurons also release GABA. Purely GABAergic 
neurons are distributed in LII, the termination area of nociceptive sensory fibers (Zeilhofer et 
al., 2012b).  
The circuitry of dorsal horn interneurons involved in spinal pain processing has not well been 
characterized, essentially due to the lack of techniques enabling the study of specific 
neuronal cell types together with their wiring to other cells. However, a plethora of 
techniques are currently used to improve the study of the dorsal horn neuronal circuitry. 
Such techniques include intersectional genetic strategies to specifically mark and ablate 
populations of inhibitory or excitatory neurons (Duan et al., 2014) or retrograde tracing to 
identify monosynaptically connected neurons (Wickersham et al., 2007).  In this project, we 
studied the contribution of glycinergic inhibitory neurotransmission onto dorsal horn neurons 
in pain signaling. To answer this question, bacterial artificial chromosome (BAC) transgenic 
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mouse line that expresses the Cre recombinase selectively in glycinergic neurons was used 
and crossed with a BAC transgenic vGAT::ChR2-YFP mouse to enable photoactivation of 
dorsal horn inhibitory neurons. Intraspinal injections of AAV vectors harboring constructs for 
cre dependent expression of diphtheria toxin subunit A (DTA) were used to ablate glycinergic 
neurons and to study the subsequent changes in inhibitory synaptic transmission to 
excitatory neurons of the dorsal horn.  
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III Aim of this chapter - Part B 
 
The aim of this project was to quantify (i) the contribution of glycine to the inhibitory input 
onto excitatory L II neurons and (ii) the loss of glycinergic input upon local segmental ablation 
of glycinergic neurons. The results of these experiments are part of a published study (Foster 
et al., 2015).  
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IV Material and methods 
 
 Animals 
Animal procedures were in accordance with the University of Zurich Centre for Laboratory 
Animals guidelines and approved by the Cantonal Veterinary Office (License permission 
64/2010, 75/2013, and 86/2013). GlyT2::Cre (Tg(Slc615-Cre)1Uze) mice were generated 
using BAC transgenesis (Zeilhofer et al., 2005), and crossed with vGAT::ChR2-YFP mice (Zhao 
et al., 2011) to obtain double transgenic mice (vGAT::ChR2; GlyT2::Cre). For the experiments, 
three to four week-old young adult vGAT::ChR2; GlyT2::Cre- (henceforth referred to as Cre-) 
and vGAT:.ChR2;GlyT2::Cre+ (henceforth referred to as Cre+) mice of either sex were used.  
Drugs and chemicals 
All chemicals were obtained from Tocris (Germany). (-)-Bicuculline methochloride (antagonist 
of GABAARs), and strychnine hydrochloride (antagonist of glycinergic receptors) were 
dissolved in extracellular solution to a final concentration of 20 µM and 0.5 µM respectively. 
Virus injection 
AAV harboring a construct for cre dependent expression of DTA (AVV-flex-DTA) were cloned 
in-house and packaged at the Penn Vector core. At P(18), intraspinal injections were made in 
mice anesthetized with 2-5% isoflurane and immobilized on a stereotaxic frame (David Kopf 
Instruments, CA, USA) equipped with computer-controlled movable axes (Neurostar, 
Germany). Lumbar vertebrae L4 and L5 were exposed, and the vertebral column was fixed 
using a pair of spinal adaptors. Mice received two unilateral injections of AAV-flex-DTA 
together with AAV-mCherry (both 1 x 109 vector particles/injection) to visualize the site of 
injection. Injections were made at a rate of 30 nl/min with glass micropipettes (tip diameter, 
30-40 µm) attached to a 10 µl Hamilton syringe, at a depth of 200-300 µm from the dorsal 
surface of the spinal cord. AAV-eGFP and AAV-mCherry were obtained from Penn Vector 
Core (Perelman School of Medicine, University of Pennsylvania) and the University of North 
Carolina (UNC) vector core, respectively. 
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Electrophysiology and optogenetic stimulation 
Four to 8 days after AAV-flex-DTA injection, mice were decapitated in deep isoflurane 
anesthesia and transverse lumbar spinal cord slices were prepared. The cutting and recovery 
solutions were prepared as described previously (Dugue et al., 2009). 300 µm thick slices 
were cut in ice-cold solution of the following composition (in mM): 130 K-gluconate, 15 KCl, 
0.05 EGTA, 20 HEPES and 25 glucose, titrated to pH 7.4 with KOH and supplemented with 50 
µM D-APV to prevent glutamate excitotoxicity. For recovery, slices were kept for 30 minutes 
in a solution containing (in mM) 225 D-Mannitol, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 0.8 CaCl2 
and 8 MgCl2 and 25 glucose (35 °C, bubbled with 95% O2, 5% CO2). Finally, slices were 
transferred to aCSF solution with the following composition (in mM): 120 NaCl, 2.5 KCl, 1.25 
NaH2PO4, 26 NaHCO3, 5 HEPES, 1 MgCl2, 2 CaCl2 and 14.6 glucose. Slices were transferred to 
a recording chamber and continuously perfused with aCSF equilibrated with 95% O2, 5% CO2 
at a flow rate of 1ml min-1 at room temperature. 
Our recordings were exclusively targeted to neurons located in the AAV1-flex-DTA infected 
red zone, visible when exciting the tissue at a 550 nm wavelength (i.e. RFP excitation 
wavelength) with the polychrome V system (Till Photonics Polychrome V, Germany). Whole-
cell patch-clamp recordings were performed using the 40x objective at room temperature. 
We used borosilicate glass recording pipettes (resistance 4-5 MΩ) filled with internal solution 
containing (in mM): 120 CsCl, 2 MgCl2 6 H2O, 10 HEPES, 0.05 EGTA, 2 MgATP, 0.1 NaGTP, 5 
QX-314 (295-310 mOsmol, pH 7.35, adjusted with CsOH) and used a HEKA EPC 9 amplifier 
controlled with Patchmaster (HEKA electronics) acquisition software. Cells were held at a 
potential of -70 mV. Light-evoked inhibitory postsynaptic currents (IPSCs) were elicited at a 
frequency of 5 stimulations min-1 by wide-field illumination of the dorsal horn. Illuminated 
area was ± 200-300 µm wide, light stimulation wavelength: 473 nm, light power: 2.7 mW, 
and light exposure: 4ms. After 10 min of stable baseline, slices were perfused with strychnine 
(stry, 0.5 µM) for 5 min. Bicuculline (bic, 20µM) was then subsequently added to strychnine 
for another 5 min. Drugs were then washed out for 15-25 min.  All electrical signals were 
sampled at 20 kHz and filtered off-line at 2.9 kHz. Data was analyzed using IgorPro 
(WaveMetrics, Inc.,USA). Access resistance of the cell was continuously monitored by giving 
short hyperpolarizing steps (-5mV) between the synaptic stimulations. Recordings were 
discarded if the access resistance changed > 20%. 
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V Results 
 
Decrease in light-evoked IPSC amplitudes after ablation of glycinergic dorsal horn neurons 
We specifically and locally ablated spinal glycinergic neurons in vivo with intraspinal injection 
of AAV-flex-DTA, (Figures 1A and 1B) by using a FLEX system for irreversible Cre-dependent 
transgene activation, which provides reliable regulation of the toxin expression (Atasoy et al., 
2008). After three AAV-flex-DTA unilateral injections at lumbar segments L3, L4, and L5, an 
eGFP reporter AAV added to the injection solution enabled us to visualize the spread of the 
AAV-flex-DTA injection in L3, L4, and L5. Infected eGFP+ cells were confined to the injected 
side with a rostrocaudal spread of about -4 mm (Figure 1C). The loss of inhibitory neurons on 
the ipsilateral and contralateral sides at lumbar segments L3-L4-L5 was identified with Pax2, a 
marker for inhibitory neurons (Cheng et al., 2004; Huang et al., 2008). Our results indicate 
reduced levels of Pax2+ neurons on the ipsilateral site of injection (Figure 1D, left) with no 
changes on the contralateral side (Figure 1D, right). Four days after intraspinal injection, the 
number of Pax2+ spinal neurons was reduced by 46.5% ± 4.0% in Cre+ mice relative to Cre- 
mice (***p<0.001, one-way ANOVA, F(2,33)=59.1, followed by Bonferroni post hoc test) 
(Figure 1F). At day 26, the loss of inhibitory neurons was only slightly larger (59.9% ± 6.0%, 
p=0.15). Ablation was most pronounced in laminae III/VI, where 65.4% ± 1.1% (***p<0.0001, 
one-way ANOVA, F(2,33)=84.1, Bonferroni post hoc test) of all inhibitory neurons were lost 
by day 4 (Figure 1F).  
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Figure 1. Specific loss of inhibitory interneurons after AAV-flex-DTA injection into the dorsal horn of Cre- and 
Cre+ mice. A, AAV-flex-DTA was injected into the lumbar dorsal horn (L3-5) of Cre- and Cre+ littermates. B, 
Expression of DTA is driven by the EF1a promoter (EF1a) and depends on Cre-mediated irreversible inversion of 
the DTA coding sequence. C, Green fluorescence (GFP) illustrates virus spread (AAV-eGFP) following three 
separate unilateral injections into the lumbar spinal cord at levels L3-L5. D, Sagittal sections of a spinal cord 
after injection of AAV-flex-DTA were stained against Pax2, a transcription factor expressed by more than 90% of 
adult spinal GAD67eGFP and GlyT2::eGFP neurons. Sections show a marked reduction of Pax2+ cells on the 
ipsilateral side (left) at lumbar segments L3 to L5 but not on the contralateral side (right). E, Confocal 
microscopy images, showing hemisections of the spinal cord (i.e., ipsilateral site to injection), reveal reduced 
Pax2 fluorescent signals (false-colored in green) Cre+ (right) compared to Cre- mice (left). F, Quantification of 
Pax2+ cells in LI-II, LIII-VI and the ventral horn of AAV-flex-DTA-injected Cre- mice (control) and AAV-flex-DTA-
injected Cre+ mice, respectively. 
To characterize potential changes in inhibitory synaptic transmission onto LI/LII after ablation 
of glycinergic neurons, we combined electrophysiology and optogenetic techniques. We 
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recorded light-evoked IPSCs from LII dorsal horn neurons, which are located on the ipsilateral 
site of injection (region identified by mCherry expression, Figure 2A). After 4 ms light 
exposure, light-evoked IPSCs displayed significantly lower amplitudes in Cre+ mice (0.62±0.10 
nA) compared to Cre- mice (1.39±0.41 nA) (Figure 2B and 2C, for statistics see figure legend).  
 
Figure 2. Reduced amplitudes of light-evoked IPSCs in AAV-flex-DTA ablation of glycinergic neurons leads to 
reduced light-evoked IPSCs in Cre+ mice compared to Cre-. A, Top, Distribution of mCherry expression in the 
spinal cord observed after unilateral injection of AAV-mCherry together with the AAV-flex-DTA virus in 
GlyT2::Cre;vGAT::ChR2 mice (scale bar 500 µm). Bottom, Schematic of the spinal cord illustrating the recording 
situation. A blue light (4 ms) pulse was applied in a region where mCherry expression (red) was visible, and 
recordings were performed from LII excitatory neurons. B, Average light-evoked IPSCs traces (black) from 21 
neurons (Cre-, left) and 23 neurons (Cre+ mice, right). Average IPSCs from individual cells are represented in light 
grey. C, Plot representing average IPSC amplitudes of individual cells (dots) in Cre- and Cre+ mice. **p < 0.01, 
unpaired Student’s t-test. Error bars represent mean±SEM. 
The glycinergic component strongly contributes to the IPSCs amplitude of Cre- and Cre+ mice  
We also investigated whether the remaining IPSCs originated from purely GABAergic neurons 
by determining the relative contribution of GABAergic and glycinergic components to IPSCs 
recorded from Cre- and Cre+ mice. Our results showed that strychnine blocked 73.0±3.5% of 
the total IPSC amplitude in Cre- mice (n=12 cells), and 78.5±3.9% in Cre+ mice (n=15 cells), 
indicating that on average more than 70% of the remaining IPSCs was glycinergic both for 
Cre- and Cre+ mice (Figure 3C). The residual portion was blocked by bicuculline (Figure 3A). 
The normalized traces of GABAergic and glycinergic IPSCs components displayed differences 
in decay kinetics, as shown in Figure 3B. As expected, glycinergic IPSCs showed a faster decay 
than GABAergic IPSCs. 
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Figure 3. Unaffected glycinergic component of IPSC amplitudes between Cre- and Cre+ after ablation of 
glycinergic neurons in the dorsal horn. A, Contribution of glycine and GABA to the IPSC amplitude in AAV-flex-
DTA-injected Cre- and Cre+ mice. Times course of the normalized light-evoked IPSCs from Cre- and Cre+ mice 
after application of strychnine (stry, 0.5 µM), applied 6 min after recording, and a combination of strychnine 
plus bicuculline (bic, 20 µM) applied 12 min after recording. Normalized IPSCs amplitudes are significantly 
reduced, and decrease further after bath application of strychnine and bicuculline. During wash-out of the 
drugs, normalized IPSCs amplitudes slightly recovered. B, Top, Example traces showing averages of 10 
consecutive light-evoked IPSCs after a 4 ms light pulse (blue bar, 4 ms) under control (ctrl) conditions, during 
application of strychnine and in the combined presence of strychnine and bicuculline. Below, Normalized traces 
(from Figure 3B, top) illustrating the different decay kinetics from the mixed IPSC (ctrl, black), GABAergic (blue), 
and glycinergic (gly, red) IPSC components. The glycinergic component was obtained by subtracting the 
GABAergic component from control IPSCs. C, Plot representing the glycinergic contribution to IPSC in individual 
cells. The contribution of the glycinergic components to IPSCs does not significantly change in Cre+ compared to 
Cre- mice, n=12 and 15 cells from Cre- (left) and Cre+ (right), respectively. p=0.49, unpaired Student t-test. Error 
bars represent mean±SEM. 
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VI Discussion 
 
In this study, a viral vector-mediated neuron manipulation was used to determine the 
contribution of local glycinergic dorsal horn neurons to pain control. The results that are 
discussed in this section are restricted to the electrophysiology results, where inhibitory 
synaptic transmission was characterized in mice after AAV-flex-DTA mediated ablation of 
dorsal horn glycinergic neurons. 
We chose an optogenetic approach to study the potential amplitude changes in inhibitory 
synaptic transmission after AAV-flex-DTA neuronal ablation. Double transgenic vGAT::ChR2-
YFP;GlyT2::Cre mice were used to answer this question. Light stimulation of the spinal dorsal 
horn enabled us to stimulate a large fraction of inhibitory neurons located in the superficial 
and deep dorsal horn simultaneously. Therefore, light-evoked IPSCs that were recorded from 
presumed excitatory neurons in LII gave us a hint on the overall inhibitory synaptic 
transmission taking place after neuronal ablation.  
The expression of vGAT::ChR2 was rendered visible in the spinal cord by the presence of YFP 
expressed as a fusion protein coupled to ChR2. The expression of vGAT::ChR2 was distributed 
across the spinal cord. In vGAT::ChR2 mice, ChR2 is expressed both in GABAergic and 
glycinergic neurons. Most vGAT::ChR2 neurons of the superficial dorsal horn are purely 
GABAergic, whereas vGAT::ChR2 neurons in LIII and deeper are most likely glycinergic 
neurons, which co-release GABA and glycine (Todd et al., 1990; Todd et al., 1996, Zeilhofer et 
al., 2012). One potential caveat of using vGAT::ChR2-YFP BAC transgenic mice, is different 
cells might express different levels of ChR2. Thus, some cells might need more light to 
depolarize and ultimately evoke somatic action potentials than others. This has been verified 
in experiments presented in Chapter 2, Figure 1.  
Comparing light evoked IPSC amplitudes after AAV-flex-DTA injection in 
vGAT::ChR2;GlyT2::Cre+ and vGAT::ChR2;GlyT2::Cre- mice revealed a significant reduction of 
inhibitory neurotransmission onto LII excitatory neurons in vGAT::ChR2;GlyT2::Cre+ mice. This 
result not only supports the fact that GlyT2::Cre+ neurons were successfully ablated by AAV-
flex-DTA virus, but also confirms the presence of strong glycinergic inhibition in the sdh, 
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which is consistent with a dense expression of glycine receptors of the α3 subtype at this site 
(Harvey et al., 2004) and abundance of the GlyT2+ neuropil in LII (Zeilhofer et al., 2005).  
vGAT::ChR2 is expressed in GABAergic and mixed GABAergic/glycinergic neurons. It was 
therefore interesting to assess the contribution of the GABAergic and glycinergic components 
to the inhibitory currents remaining in GlyT2::Cre+ mice after AAV-flex-DTA ablation. Given 
the resistance of purely GABAergic neurons to AAV-flex-DTA in GlyT2::Cre mice, it was 
expected that the relative contribution of GABA to the total IPSC amplitude would increase 
after AAV-flex-DTA mediated neuron ablation. The fact that this was not the case may 
suggest that excitatory neurons of the superficial dorsal horn receive most of their inhibitory 
input from the deep dorsal horn where most inhibitory neurons are mixed 
GABAergic/glycinergic. The remaining inhibition would then most likely come from deep 
dorsal horn inhibitory neurons located in segments not targeted by the virus injection. This 
result is fully consistent with the mapping data obtained in Chapter 2, Part A that showed 
connection formed between deep dorsal horn inhibitory neurons and superficial dorsal horn 
excitatory neurons.  
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General discussion and outlook 
 
Correct functioning of spinal GABAergic and glycinergic neurons is important for maintaining 
a physiological level of inhibitory neurotransmission in the dorsal horn. It is firmly established 
that a reduction of the inhibitory drive (i.e., disinhibition) contributes to pathological pain 
states, which in mice translates into increased sensitivity to innocuous inputs (i.e., allodynia), 
and enhanced sensitivity to noxious stimuli (i.e., hyperalgesia) (Zeilhofer et al., 2012b). Thus, 
a functional inhibitory network is crucial for controlling the excitability of output neurons in 
the superficial dorsal horn (sdh), and strongly influences the final nociceptive output to the 
brain.  
In Chapter 1 of this thesis, I characterized inhibitory neurotransmission onto sdh excitatory 
neurons in mice lacking spinal α2-GABAARs. Our electrophysiological study showed reduced 
synaptic inhibition in the hoxb8α2-/- animals compared to control animals. This result goes in 
line with a previous study in our group that provided evidence for reduced GABAergic 
inhibition in the hoxb8α2-/- animals compared to control animals (Paul et al., 2014) and 
therefore emphasizes on the role of α2-GABAARs as important subtypes mediating GABAergic 
inhibition in the sdh. A former study revealed high expression of α2-GABAARs in the sdh by 
using α subunit-specific antibodies (Paul et al., 2012). The high expression level of α2-
GABAARs in the sdh might also explain the reduction in synaptic transmission that we 
observed in the hoxb8α2-/- animals.  
In addition to assessing inhibitory synaptic transmission using electrophysiological recordings, 
we conducted behavioral experiments comparing the baseline thresholds of α2fl/fl and 
hoxb8α2-/- mice to acute nociception. To our surprise, baseline pain sensitivities to acute pain 
tests were similar in both genotypes. The discrepancy between the synaptic and behavioral 
phenotype suggests the presence of compensatory mechanisms that could take place at a 
cellular or molecular level. Increased tonic inhibition in hoxb8α2-/- animals is one mechanism 
we thought might compensate for reduced synaptic inhibition. Tonic inhibition is mediated 
by extrasynaptic receptors in response to GABA present outside the synapse (Farrant and 
Nusser, 2005) and depends mainly on the expression of the α4-δ or α5 containing GABAARs 
subtypes (Fritschy and Panzanelli, 2014). Evidence was provided that GABAergic tonic 
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inhibition was mediated by α4 or α5-GABAARs in some neurons of LII (Takahashi et al., 2006). 
In fact, I provide evidence that in hoxb8α2-/- animals, tonic inhibition is significantly 
increased. It is tempting to hypothesize that increased tonic inhibition could originate from 
an up-regulation of extrasynaptic α5-GABAARs subtypes displaying stronger affinities for 
GABA (Perez-Sanchez et al., 2016). Although it was reported that synaptic GABAARs are 
directly recruited from the extrasynaptic pool (Gerrow and Triller, 2014), one could speculate 
that the few α5-GABAARs that are found at the synaptic site (Gerrow and Triller, 2014), could 
serve as a reserve for extrasynaptic receptors and diffuse laterally to these sites when the 
activity of tonic inhibition has to be elicited (e.g. in hoxb8α2-/- mice). Lateral diffusion was 
indeed described as a mechanism promoting receptor dynamics and diffusion across the 
plasma membrane (Triller and Choquet, 2005). An up-regulation of extrasynaptic α5-
GABAARs may therefore have compensated the loss of synaptic α2-GABAARs. However, in our 
behavioral experiments hoxb8α2-/- mice suffering from inflammatory pain showed no 
analgesia after treatment with HZ-166.  
Alternatively, a possible contribution of α4/δ-GABAARs should be considered. Under baseline 
conditions α4-GABAARs were shown to be expressed in the sdh layers only at low levels (Paul 
et al., 2012). However, several reports suggest that α4-GABAARs are up-regulated in pain 
states and that their targeting with the specific α4-GABAAR subtype modulator 4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridine-3-ol (THIP) produces analgesia. It is at least possible that a 
similar up-regulation of α4 subunit occurs in the spinal cord of hoxb8α2-/- mice. To distinguish 
between α4-GABAAR and α5-GABAARs future experiments might use subtype selective 
modulators such as THIP which selectively facilitates α4-GABAARs and L-655,708 which 
selectively inhibits α5-GABAARs.  
We next investigated whether we would observe changes from the excitatory input of 
nociceptors. We hypothesized that reduced excitatory neurotransmission onto LII neurons 
might compensate for the loss of synaptic inhibition. We checked the mRNA expression levels 
of VgluTs in DRG neurons to indirectly test if there would be less glutamate release from 
terminals of small-diameter primary afferents. We found that hoxb8α2-/- mice had reduced 
VgluT2 mRNA levels in neurons of the DRGs. VgluT2 is expressed by unmyelinated peptidergic 
fibers (Todd et al., 2003), therefore we could expect reduced excitatory inputs onto dorsal 
horn neurons. However, our electrophysiological results showed no difference in the 
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amplitude or reliability of light-evoked EPSCs in hoxb8α2-/- mice compared to α2fl/fl mice, 
suggesting that the loss of synaptic inhibition had no impact on the excitatory drive 
originating from small-diameter primary afferents onto dorsal horn neurons. In addition, we 
investigated the protein expression levels of VgluT1, 2, and 3 in the spinal dorsal horn of α2fl/fl 
and hoxb8α2-/- mice. In the dorsal horn, the expression of VgluTs is mainly found on terminals 
of primary sensory fibers (Todd et al., 2003; Seal et al., 2009). We found a small yet 
significant increase of VgluT3 in the sdh, the main expression site of VgluT3 in the spinal cord 
(Seal et al., 2009).  
Furthermore, we investigated expression levels of serotonin in the dorsal horn. It is well 
established that serotonin can modulate the nociceptive pathway by mediating either 
pronociceptive or antinociceptive effects, which will rely on the type of 5-HT receptors found 
on the postsynaptic neuron (Bowker et al., 1981; Liu et al., 2002; Fukushima et al., 2009; Kim 
et al., 2015). Our results showed increases in serotonin and TPH2 in the spinal cord of 
hoxb8α2-/- mice, suggesting that an increase of serotonin in hoxb8α2-/- mice could be another 
mechanism to counteract the behavioral consequences of reduced GABAergic synaptic 
inhibition (Antal et al., 1996). Whether this increased serotonergic input is the main 
compensatory mechanism should be assessable in experiments using 5,7 DHT, which leads to 
the degeneration of serotonergic and noradrenergic axon terminals (Gross et al., 1985). 
When applied together with desipramine the ablation becomes specific for serotonergic 
terminals (Todurga et al., 2016). It has been reported that intrathecal injection of 5,7- 
dihydroxytryptamine (5,7 DHT) given together with desipramine does not change nociceptive 
thresholds in naïve wild-type mice (Yanarates et al., 2010). It might be interesting to test its 
effect in hoxb8α2-/- mice. 
In the first part of Chapter 2, I focused on locating the origin of inhibitory synaptic inputs onto 
dorsal horn neurons. From our mapping experiments, it became clear that most of the 
inhibitory input zones originated from the dorsal horn grey matter which was expected since 
most of the inhibitory neurons are located in the grey matter (Todd and Spike, 1993; 
Zeilhofer et al., 2012b). Surprisingly, some excitatory LII neurons also received inhibitory 
inputs from the white matter. One possible explanation would be that LII excitatory neurons 
have dendrites that extend into the spinal white matter. Although the morphology of cells in 
LII is very diverse, it is known that LII neurons exhibit a predominant rostro-caudal spread of 
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their dendrites (Grudt and Perl,2002). Therefore, to confirm a possible spread of the 
dendritic tree to the white matter additional mapping and reconstruction should be 
performed in parasagittal spinal cord slices (Kato et al., 2007). In addition, our preliminary 
experiments revealed inhibitory inputs from supraspinal territories from the RVM to LII 
excitatory neurons. This might reflect synapses between dendrites of LII neurons and axons 
of the descending fibers, thereby explaining the presence of inhibitory input zones in the 
white matter (Antal et al., 1996). Preliminary dendritic tree reconstructions performed on LII 
excitatory neurons revealed the presence of ventrally expanding dendrites to the deep dorsal 
horn. From previous work, this morphology would correspond to vertical cells (Grudt and 
Perl, 2002). Our results show that some LII excitatory neurons receive inhibitory inputs from 
the deep dorsal horn, which could indicate the presence of feed-forward inhibition from 
myelinated low-threshold primary afferent fibers (LTMRs) in LIII, known to terminate in this 
area (Braz et al., 2014), to excitatory interneurons in LII (Yasaka et al., 2014). Although axons 
of some LII excitatory neurons were found to project onto LI projection neurons (Lu and Perl, 
2005; Maxwell et al., 2007; Yasaka et al., 2010), further reconstruction of the axon would be 
needed to confirm the presence of polysynaptic pathways linking LTMRs to lamina I via the 
recorded neuron in LII (Lu and Perl, 2005; Torsney and MacDermott, 2006; Lu et al., 2013). 
One limitation of our mapping experiments is not being able to distinguish somatic or axon 
stimulation and stimulation of axon terminal. Using a blocker for action potential firing (TTX) 
could allow us to exclusively stimulate the synaptic terminals. Reinforcing the depolarization 
of the terminals by 4-AP might be needed to evoke reliable neurotransmitter release (DePuy 
et al., 2013; Wang et al., 2014). Mapping monosynaptic neurotransmission would improve 
our characterization of the inhibitory input zones onto LII excitatory neurons. Indeed, this 
would reveal direct synapses taking place onto structures of the postsynaptic neuron such as 
dendrites and thereby indicate the regions in which the dendrites of the postsynaptic neuron 
extend to (Kato et al., 2007; Kato et al., 2013). With this approach, we would gain even more 
detailed information in the circuitry between LII excitatory neurons and inhibitory dorsal horn 
neurons, relevant in nociceptive signaling. 
In the second part of Chapter 2, I characterized inhibitory synaptic transmission onto 
excitatory neurons in which dorsal horn glycinergic neurons were ablated by AAV-flex-DTA 
virus. We specifically defined the role of glycinergic neurons in mediating inhibitory control of 
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excitatory spinal cord neurons using optogenetic tools and confirmed their critical role in 
nociceptive signaling (Foster et al., 2015). These results hereby provide a direct proof of what 
has been proposed by other groups (Todd and Sullivan, 1990; Todd, 1996; Keller et al., 2001). 
Therefore, pharmacological targeting of glycinergic receptors in the superficial dorsal horn to 
restore inhibitory activity would constitute an alternative approach to targeting GABAARs 
(Acuña et al., 2016). An advantage of this approach is the restricted expression of glycinergic 
innervation in the hindbrain and spinal cord (Zeilhofer et al., 2005), therefore unwanted 
effects such as sedation or addiction, would be less likely when modulating glycinergic 
receptors (Acuña et al., 2016).  
In summary, in the first part of my thesis I describe two possible homeostatic plastic changes, 
namely increased tonic inhibition and increased serotonergic neurotransmission, which may 
explain the absence of enhanced sensitivity to pain in mice lacking α2-GABAARs. I show that 
in mice with reduced synaptic inhibition, an underlying cause of chronic pain, the organism is 
able to counter-balance such loss by increasing GABAergic-mediated tonic inhibition and 
facilitating serotonergic spinal neurotransmission. Furthermore, I confirmed that 
pharmacologically targeting α2-GABAARs with a novel benzodiazepine HZ-166 appears to be 
effective in reducing pain. In the second part of my thesis, I established a new strategy to 
optogenetically map the origin of the inhibitory input zones onto spinal cord excitatory 
neurons. Characterizing the origin of inhibitory input zones provides additional insights on 
the influence of dorsal horn inhibitory neurotransmission in nociceptive signaling. These 
results highlight the existence of a complex GABAergic and glycinergic inhibitory network 
involved in controlling the excitability of excitatory interneurons in LII of the dorsal horn.  
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